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A B S T R A C T
Background
Inpatient treatment is an expensive way of caring for people with acute psychiatric disorders. It has been proposed that many of those
currently treated as inpatients could be cared for in acute psychiatric day hospitals.
Objectives
To assess the effects of day hospital versus inpatient care for people with acute psychiatric disorders.
Search methods
We searched theCochrane SchizophreniaGroupTrials Register (June 2010)which is based on regular searches ofMEDLINE, EMBASE,
CINAHL and PsycINFO. We approached trialists to identify unpublished studies.
Selection criteria
Randomised controlled trials of day hospital versus inpatient care, for people with acute psychiatric disorders. Studies were ineligible
if a majority of participants were under 18 or over 65, or had a primary diagnosis of substance abuse or organic brain disorder.
Data collection and analysis
Two review authors independently extracted and cross-checked data. We calculated risk ratios (RR) and 95% confidence intervals (CI)
for dichotomous data. We calculated weighted or standardised means for continuous data. Day hospital trials tend to present similar
outcomes in slightly different formats, making it difficult to synthesise data. We therefore sought individual patient data so that we
could re-analyse outcomes in a common format.
Main results
Ten trials (involving 2685 people) met the inclusion criteria. We obtained individual patient data for four trials (involving 646 people).
We found no difference in the number lost to follow-up by one year between day hospital care and inpatient care (5 RCTs, n = 1694,
RR 0.94 CI 0.82 to 1.08). There is moderate evidence that the duration of index admission is longer for patients in day hospital care
than inpatient care (4 RCTs, n = 1582, WMD 27.47 CI 3.96 to 50.98). There is very low evidence that the duration of day patient
care (adjusted days/month) is longer for patients in day hospital care than inpatient care (3 RCTs, n = 265, WMD 2.34 days/month CI
1.97 to 2.70). There is no difference between day hospital care and inpatient care for the being readmitted to in/day patient care after
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discharge (5 RCTs, n = 667, RR 0.91 CI 0.72 to 1.15). It is likely that there is no difference between day hospital care and inpatient
care for being unemployed at the end of the study (1 RCT, n = 179, RR 0.88 CI 0.66 to 1.19), for quality of life (1 RCT, n = 1117,
MD 0.01 CI -0.13 to 0.15) or for treatment satisfaction (1 RCT, n = 1117, MD 0.06 CI -0.18 to 0.30).
Authors’ conclusions
Caring for people in acute day hospitals is as effective as inpatient care in treating acutely ill psychiatric patients. However, further data
are still needed on the cost effectiveness of day hospitals.
P L A I N L A N G U A G E S U M M A R Y
Day hospital versus admission for acute psychiatric disorders
Day hospitals are a less restrictive alternative to inpatient admission for people who are acutely and severely mentally ill. This review
compares acute day hospital care to inpatient care. We found that at least one in five patients currently admitted to inpatient care could
feasibly be cared for in an acute day hospital. Patients treated in the day hospital had the same levels of treatment satisfaction and quality
of life as those cared for as inpatients. The day hospital patients were also no more likely to be unemployed at the end of their care.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Day hospital compared to Inpatient for acute psychiatric disorders
Patient or population: patients with acute psychiatric disorders
Settings:
Intervention: day hospital
Comparison: inpatient
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Inpatient Day hospital
Feasibility and engage-
ment: lost to follow-up
by 1 year
Follow-up: 10 to 12
months
Low1 RR 0.94
(0.82 to 1.08)
1694
(5 studies2)
⊕⊕⊕©
moderate3
100 per 1000 94 per 1000
(82 to 108)
Moderate1
300 per 1000 282 per 1000
(246 to 324)
High1
500 per 1000 470 per 1000
(410 to 540)
Extent of hospital care:
1. duration of index ad-
mission
Follow-up: 10 to 12
months
The mean extent of hos-
pital care: 1. duration of
index admission ranged
across control groups
from
-4.6 to 55.5 days
The mean extent of hos-
pital care: 1. duration of
index admission in the in-
tervention groups was
27.47 higher
(3.96 to 50.98 higher)
1582
(4 studies2)
⊕⊕⊕©
moderate3
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Extent of hospital care:
3. duration of day patient
care (adjusted days/
month)
Follow-up: 10 to 12
months
The mean extent of
hospital care: 3. du-
ration of day patient
care (adjusted days/
month) ranged across
control groups from
2.1 to 3.6 days /month
The mean extent of hos-
pital care: 3. duration of
day patient care (adjusted
days/month) in the inter-
vention groups was
2.34 higher
(1.97 to 2.7 higher)
465
(3 studies)
⊕©©©
very low4,5
Extent of hospital care:
5. readmitted to in/day
patient care after dis-
charge
Follow-up: 10 to 24
months
Low1 RR 0.91
(0.72 to 1.15)
667
(5 studies)
⊕©©©
very low6,7
100 per 1000 91 per 1000
(72 to 115)
Moderate1
300 per 1000 273 per 1000
(216 to 345)
High1
500 per 1000 455 per 1000
(360 to 575)
Unemployed (at end of
study)
Follow-up: 2 to 12
months
Low1 RR 0.81
(0.67 to 0.97)
320
(2 studies)
⊕⊕©©
low8,9
200 per 1000 162 per 1000
(134 to 194)
Moderate1
600 per 1000 486 per 1000
(402 to 582)
High1
900 per 1000 729 per 1000
(603 to 873)
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Quality of life: average
overall role score - at 12
months
MANSA - Manchester
Short Assessment of
Quality of Life
Follow-up: 12 months
The mean quality of life:
average overall role score
- at 12 months in the con-
trol groups was
0.01
The mean quality of life:
average overall role score
- at 12 months in the in-
tervention groups was
0.01 higher
(0.13 lower to 0.15
higher)
1117
(1 study2)
⊕⊕⊕©
moderate10
Treatment satisfaction:
average overall role
score - at discharge
CAT - Client Assessment
of Treatment
Follow-up: 12 months
The mean treatment sat-
isfaction: average overall
role score - at discharge
in the control groups was
8.06 points
The mean treatment sat-
isfaction: average overall
role score - at discharge
in the intervention groups
was
0.06 higher
(0.18 lower to 0.3 higher)
1117
(1 study2)
⊕⊕⊕©
moderate10
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the
comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RR: risk ratio.
GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1 Middle level of control risk approximates to that of the control risk in the trials.
2 One large (n = 1117) high-quality multi-centre RCT (Kallert-EU-2007) provides data for all outcomes. This trial carries more weight
than other pooled trials and this was taken into consideration when assessing overall risk of bias.
3 Inconsistency: rated ’serious’ - heterogeneity not explained by differences in populations/interventions. With removal of Sledge-US-1996
(high risk of bias, different results from other included trials) data become homogeneous.
4 Risk of bias: rated ’very serious’/of 3 relevant RCTs, 1 - inadequate sequence generation and allocation concealment, none addressed
incomplete data adequately. It was unclear in all whether they were free from other biases.
5 There was heterogeneity for this outcome, which is not explained by differences in the populations and interventions used in the
studies.
6 Risk of bias: rated ’very serious’. Of 5 relevant RCTs, 2 had inadequate sequence generation, 3 had inadequate allocation concealment,
none addressed incomplete data adequately and it was unclear whether any were free from other biases.
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7 Imprecision: rated ’serious’. 95% confidence intervals very wide.
8 Risk of bias: rated ’serious’. 2 relevant RCTs, 1 had inadequate sequence generation and allocation concealment, incomplete data not
addressed, it was unclear whether they were free from other biases.
9 Publication bias: rated ’strongly suspected’. Only two studies reported on this outcome.
10 Publication bias: rated ’strongly suspected’. Only one study reported on this outcome.
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B A C K G R O U N D
Description of the condition
Despite the growth of community care, many people with acute
psychiatric disorders continue to be treated as inpatients (DoH
1996). This is an expensive way of caring for such patients (Audit
Comm1994) and surveys suggest that it is oftenunnecessary (Beck
1997). It has been proposed that many of those currently treated
as inpatients could instead be treated in day hospitals (Pang 1985).
Description of the intervention
The psychiatric day hospital has been defined as a unit that pro-
vides “diagnostic and treatment services for acutely ill patients
who would otherwise be treated on traditional psychiatric inpa-
tient units” (Rosie 1987). The acute psychiatric day hospital is to
be distinguished from other types of “partial hospitalisation” or
“day care” such as transitional care for patients leaving hospital,
more intensive alternatives to outpatient care (day treatment pro-
grammes) and support of long-term patients living in the com-
munity (day care centres) (Hoge 1992; Rosie 1987).
Psychiatric day hospitals were first described in the Soviet Union
in the 1930s where they arose as a result of bed shortages (Volovik
1986). The firstNorth American day hospital was opened inMon-
treal, Quebec in 1946, also in an attempt to reduce the demand for
inpatient beds (Cameron 1947). In the USA day hospitals became
a popular way of treating people in the 1960s following the 1963
Community Mental Health Center Construction Act, which set
in law the need to establish partial hospitalisation programmes
(Pang 1985). Similar developments encouraged the growth of day
hospitals in the UK in the 1960s, and in theNetherlands andWest
Germany in the 1970s (Schene 1986). In the 1980s, however,
research commissioned by the American Psychiatric Association
showed widespread closure of partial hospitalisation programmes
and a low rate of growth in the numbers of patients served by such
programmes (Krizay 1989).
A number of factors appear to have contributed to the decline.
First, there was a growing awareness of the limited evidence for
the effectiveness and cost effectiveness of day hospitals (Creed
1989; Vaughn 1983). Second, day hospitals faced competition
from more radical “non-institutional” alternatives, such as as-
sertive community treatment (Hoge 1992). Third, confusion over
the role of day hospitals led to some becoming expensive day cen-
tres, as they were overwhelmed by inappropriately placed long-
term patients (Pryce 1982). Despite these problems, remorseless
pressure on inpatient facilities has led to continued interest in psy-
chiatric day hospitals and has inspired the development of new-
style day hospitals augmented by outreach services, crisis beds,
and extended hours programmes (Creed-UK-1996; Schene 1988;
Sledge-US-1996).
How the intervention might work
Proponents have claimed that day hospitals can providemore cost-
effective care by: promoting quicker recovery (Cameron 1947),
improving social functioning (Greene 1981; Schene 1986), reduc-
ing family burden (Pang 1985), shortening the duration of hos-
pital care (Parker 1990) and reducing relapse rates (Moscowitz
1980).
Why it is important to do this review
Despite 50 years of research, opinion remains divided on the
cost effectiveness of day hospital treatment. Critics highlight the
high rates of patients lost to follow-up in day hospital studies
(Wilkinson 1984), and question whether day hospital treatment
might actually ’institutionalise’ patients by encouraging them to
attend for overlong periods of time (Hoge 1992).
O B J E C T I V E S
1. Primary objective
To assess the effects of admission to a psychiatric day hospital
versus admission to inpatient care for people with acute psychiatric
disorders.
The main hypothesis was that admission to a day hospital would
reduce the extent of hospital care and total costs of care, without
any deterioration in follow-up rates or clinical and social function-
ing.
2. Secondary objectives
To determine:
• for what proportion of acutely ill patients day hospital
treatment was feasible;
• whether patients recover at the same rate in day hospital
treatment (in terms of symptoms and social functioning); and
• how far clinical and social recovery was affected by personal
characteristics such as diagnosis, sex, and age.
The review was not concerned with the other modes of ’partial
hospitalisation’ listed above, i.e. day treatment programmes and
day centres, which have been reviewed elsewhere (Marshall 2001).
The use of partial hospitalisation as a form of transitional care is
also reviewed elsewhere on theCochrane Library (Johnstone 2001).
M E T H O D S
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Criteria for considering studies for this review
Types of studies
We considered all relevant randomised controlled trials (RCTs), as
well as economic evaluations conducted alongside included RCTs.
We excluded quasi-RCTs, such as those allocating by using alter-
nate days of the week. Where trials were described in some way as
to suggest or imply that the study was randomised and where the
demographic details of each group’s participants were similar, we
included trials and undertook sensitivity analysis to the presence
or absence of these data.
Types of participants
People with acute psychiatric disorders, diagnosed by any criteria,
who would have been admitted to inpatient care if acute day hos-
pital care had not been available.
Studies were not eligible if they were restricted to, or included a
majority of, patients who were aged under 18 or over 65, or who
had a primary diagnosis of substance abuse and/or organic brain
disorder.
Types of interventions
1. Acute psychiatric day hospitals
We have defined these as units that provided diagnostic and treat-
ment services for acutely ill patients who would otherwise be
treated on traditional psychiatric inpatient units.
2. Standard inpatient care
Types of outcome measures
Weanalysed the followingoutcomes for different lengths of follow-
up: up to three months, six months or more than six months.
Primary outcomes
1. Lost to follow-up
Secondary outcomes
1. Feasibility and engagement
1.1 Unsuitable for day patient care
2. Extent of hospital care
2.1 Duration of initial admission
2.2 Days in inpatient care
2.3 Days in day patient care
2.4 Days in inpatient or day patient care
2.5 Re-admitted to inpatient or day patient care after discharge
3. Clinical and social outcomes
3.1 Mental state
3.2 Social functioning
3.3 Burden on carers
3.4 Deaths
3.5 Employed at end of study
3.6 Satisfaction with care
3.7 Quality of life
4. Costs of care
4.1 Cost of index admission
4.2Cost of hospital care (meanmonthly - comprising cost of index
admission plus cost of subsequent admissions)
4.3 Cost of psychiatric care (mean monthly - comprising cost of
hospital care plus cost of all ambulatory psychiatric care)
4.4 Cost of all care (meanmonthly - comprising cost of psychiatric
care plus costs of other medical/social care, but excluding wages,
costs to relatives, and transfer payments)
Search methods for identification of studies
Electronic searches
1. Cochrane Schizophrenia Group Trials Register (June 2010)
We searched the register using the phrase:
(day?care* or day?cent* or day?hosp* in interventions field in
STUDY)]
This register is compiled by systematic searches ofmajor databases,
hand searches and conference proceedings (see group module).
For details of previous electronic search - please see Appendix 1.
Searching other resources
1. Reference searching
We inspected references of all identified studies for further relevant
studies.
8Day hospital versus admission for acute psychiatric disorders (Review)
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2. Personal contact
We contacted the first author of each included study for informa-
tion regarding unpublished trials.
Data collection and analysis
Selection of studies
In the first version of this review, MM and AA independently in-
spected abstracts of the reports identified by the search. We iden-
tified potentially relevant abstracts (i.e. those in which a group of
day hospital patients meeting the patient inclusion criteria were
compared against a control group) and ordered full papers. A re-
liability study found complete agreement on which trials met in-
clusion criteria.
In the latest version, reviewer NM inspected all abstracts of studies
identified as above and identified potentially relevant reports. In
addition, to ensure reliability, KSW inspected a random sample of
these abstracts, comprising 10% of the total. Where disagreement
occurred we resolved this by discussion, or where there was still
doubt, we acquired the full article for further inspection.Whenwe
had acquired the full articles of relevant reports for reassessment,
we carefully inspected for a final decision on inclusion (see Criteria
for considering studies for this review). Once we had obtained the
full articles, NM and KSW in turn inspected all full reports and
independently decided whether they met inclusion criteria. NM
and KSW were not blinded to the names of the authors, insti-
tutions or journal of publication. Where difficulties or disputes
arose, we asked author JM for help and if it was impossible to
decide, added these studies to those awaiting assessment and con-
tacted the authors of the papers for clarification.
Data extraction and management
1. Extraction
1.1 Data regarding criteria and outcomes
In the first version of the review, where further clarification was
needed, we contacted the authors of trials to provide missing data.
We sought individual patient data for all patients randomised in
eligible trials (published or unpublished).We verified all individual
patient data received against the original trial reports. We resolved
any queries by contacting the trialists. For trials where individual
patient data were not available, two authors extracted categorical
and continuous data separately from trial reports and another cross
checked (MM and either AA or RC).
In the latest version, authors NM and KSW independently ex-
tracted data from the single included study. We discussed any dis-
agreement and documented decisions. With remaining problems
JM helped clarify issues and we documented those final decisions.
We extracted data presented only in graphs and figures whenever
possible, but included them only if two authors independently
had the same result.
1.2 Additional data
1.2.1 Feasibility of hospital treatment
We have defined the feasibility of day hospital treatment as the
percentage reduction in acute inpatient admissions that could be
achieved by diverting patients to an acute day hospital. We esti-
mated feasibility by a modification of the method suggested by
Kluiter (Wiersma-NL-1989), the general formula being: 100 x
number engaging in day hospital treatment/(number assessed for
eligibility x R), where R is the randomisation ratio for the trial
(defined as number randomised to day hospital divided by num-
ber of patients randomised). However, estimates of feasibility are
profoundly affected by judgements about what is ’engagement’ in
day hospital treatment and how many patients have been assessed
for eligibility. We therefore decided to perform a sensitivity analy-
sis to give a best and worst estimate of feasibility for each included
trial.
We based the best estimate on defining: i. engagement in day hos-
pital as the number randomised to day hospital treatment; and ii.
assessed for eligibility as the number remaining after exclusions
for administrative reasons. We defined patients excluded for ad-
ministrative reasons as those who were too well to be randomised
to day care, left before they could be assessed or lived outside the
study catchment area. We based the worst estimate of feasibility
on defining: i. engagement in day hospital as the number ran-
domised to day hospital treatment (those admitted as inpatients
in the first four weeks + the number of day patients who did not
turn up for day hospital treatment); and ii. assessed for eligibility
as the number presenting for admission before any administrative
exclusions were made. We derived a weighted average for the best
and worst estimates of feasibility derived in this way. However, for
a minority of trials (referred to as ’Type 2’ trials, see Description
of studies below), we could not apply this formula for calculating
feasibility because all patients were admitted to inpatient care be-
fore randomisation to continuing inpatient care or day hospital
care. For these trials, we calculated a single estimate of feasibility,
based on those patients randomised to day hospital care who ex-
perienced only a brief episode of inpatient care before transfer to
a day hospital. We estimated number lost to follow-up by taking
the number who were not re-interviewed at the final follow-up as-
sessment. We assumed that clients lost to follow-up also dropped
out of care.
1.2.2 Economic data
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We have not combined individual patient data on economic vari-
ables across trials because there is no agreed method for over-
coming the problems caused by differences in costing methodol-
ogy between trials and between countries. Instead, we have pre-
sented these data adjusted to a common format (see Types of
outcome measures above) in the currencies used in the original
trials. We then calculated percentage differences in costs between
treatment and control conditions and, where possible, compared
costs of treatment and control care using non-parametric tests. For
Creed-UK-1990, we calculated costs of hospital care using indi-
vidual patient data, working on the assumption that the relative
costs of day hospital and inpatient care were similar to those re-
ported in Creed-UK-1996 (both trials took place in the same day
hospital with the same general hospital control).
2. Management
2.1 Forms
We extracted data onto standard, simple forms.
2.2 Scale-derived data
We included continuous data from rating scales only if:
a) the psychometric properties of the measuring instrument had
been described in a peer-reviewed journal (Marshall 2000); and
b) the measuring instrument was not written or modified by one
of the trialists for that particular trial; and
c) themeasuring instrument is either i. a self-report or ii. completed
by an independent rater or relative (not the therapist).
2.3 Endpoint versus change data
We preferred to use scale endpoint data, which typically cannot
have negative values and are easier to interpret from a clinical point
of view. Change data are often not ordinal and are very problematic
to interpret. If endpoint data were unavailable, we used change
data.
2.4 Skewed data
2.4.1 General
Continuous data on clinical and social outcomes are often not
normally distributed. To avoid the pitfall of applying paramet-
ric tests to non-parametric data, we aim to apply the following
standards to all data before inclusion: a) standard deviations and
means are reported in the paper or obtainable from the authors;
b) when a scale starts from the finite number zero, the standard
deviation, when multiplied by two, is less than the mean (as oth-
erwise the mean is unlikely to be an appropriate measure of the
centre of the distribution, (Altman 1996); c) if a scale starts from
a positive value (such as PANSS which can have values from 30
to 210) we will modify the calculation described above to take the
scale starting point into account. In these cases skew is present if
2SD>(S-S min), where S is the mean score and S min is the mini-
mum score. Endpoint scores on scales often have a finite start and
end point and these rules can be applied. When continuous data
are presented on a scale which includes a possibility of negative
values (such as change data), it is difficult to tell whether data are
skewed or not. We entered skewed data from studies of less than
200 participants in additional tables rather than into an analysis.
Skewed data pose less of a problem when looking at means if the
sample size is large and were entered into syntheses.
2.4.2 Specific
Data concerning use of hospital care were skewed, but we have
nonetheless presented them on Review Manager (RevMan 2008)
to facilitate comparison between trials. However, the results of any
parametric analyses on these data were cross-checked using the
non-parametric Mann-Whitney U statistic.
2.5 Common measure
To facilitate comparison between trials, we converted variables that
can be reported in differentmetrics, such as days in hospital (mean
days per year, per week or per month) to a common metric (e.g.
mean days per month). We adjusted time spent in the day hospital
so that ’days in day hospital’ represented the actual number of at-
tendances at the day hospital (excluding missed days), rather than
the total time for which the patient was a day hospital patient (ex-
cept in the case of duration of initial admission). Creed-UK-1990
did not distinguish between duration of care and actual number
of attendances, so actual number of attendances was estimated
using the same ratio of duration: actual attendances reported in
Creed-UK-1996 (which took place in the same day hospital using
the same hospital control).
2.6 Conversion of continuous to binary
Where possible, we attempted to convert outcome measures to di-
chotomous data. This could be done by identifying cut-off points
on rating scales and dividing participants accordingly into ’clini-
cally improved’ or ’not clinically improved’.We generally assumed
that, if there had been a 50% reduction in a scale-derived score
such as the Brief Psychiatric Rating Scale (BPRS, Overall 1962)
or the Positive and Negative Syndrome Scale (PANSS, Kay 1986),
this could be considered as a clinically significant response (Leucht
2005a; Leucht 2005b). If data based on these thresholds were not
available, we used the primary cut-off presented by the original
authors.
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2.7 Direction of graphs
Where possible, we entered data in such a way that the area to
the left of the line of no effect indicates a favourable outcome for
acute day hospital care.
2.8 Summary of findings table
We included the following short- or medium-term outcomes in a
summary of findings table. (KSWwas not biased by being familiar
with the data.)
1. Discontinuation of treatment
2. Extent of hospital care
• Duration of index admission
• Days in day patient care
• Readmitted to in/day patient care after discharge
3. Clinical and social outcomes
• Unemployed
• Quality of life
• Treatment satisfaction
4. Costs of care
• Cost of all care (mean monthly - comprising cost of
psychiatric care plus costs of other medical/social care, but
excluding wages, costs to relatives, and transfer payments).
Assessment of risk of bias in included studies
KSW and NM independently assessed the risk of bias of each
trial using The Cochrane Collaboration’s risk of bias tool (Higgins
2009). We created a form following the guidance to make judg-
ments on the risk of bias in six domains: sequence generation;
allocation concealment; blinding (of participants, personnel, and
outcome assessors); incomplete outcome data; selective outcome
reporting; and other sources of bias. We categorised these judg-
ments as ’yes’ (low risk of bias), ’no’ (high risk of bias), or ’unclear’.
We resolved disagreements through discussion and by consulting
MM.
Measures of treatment effect
1. Binary data
For binary outcomes we calculated a standard estimation of the
risk ratio (RR) and its 95% confidence interval (CI). It has been
shown that RR is more intuitive (Boissel 1999) than odds ratios
and that odds ratios tend to be interpreted as RR by clinicians
(Deeks 2000). For statistically significant results we had planned to
calculate the number needed to treat to provide benefit/to induce
harm statistic (NNTB/H), and its 95% CI using Visual Rx (http:
//www.nntonline.net/), taking account of the event rate in the
control group. This, however, was superseded by Summary of
findings for the main comparison and the calculations therein.
2. Continuous data
For continuous outcomeswe estimated a random-effectsmean dif-
ference (MD) between groups. We preferred not to calculate effect
size measures (standardised mean difference (SMD)). However, in
the case of where scales were of such similarity to allow presuming
there was a small difference in measurement, we calculated it and,
whenever possible, we transformed the effect back to the units of
one or more of the specific instruments.
Unit of analysis issues
1. Cluster trials
Studies increasingly employ ’cluster randomisation’ (such as ran-
domisation by clinician or practice) but analysis and pooling of
clustered data poses problems. Authors often fail to account for
intraclass correlation in clustered studies, leading to a ’unit of
analysis’ error (Divine 1992) whereby P values are spuriously low,
CI unduly narrow and statistical significance overestimated. This
causes type I errors (Bland 1997; Gulliford 1999).
Where clustering is not accounted for in primary studies, we pre-
sented data in a table, with a (*) symbol to indicate the presence
of a probable unit of analysis error. In subsequent versions of this
review we will seek to contact first authors of studies to obtain intr-
aclass correlation coefficients for their clustered data and to adjust
for this by using accepted methods (Gulliford 1999). Where clus-
tering had been incorporated into the analysis of primary studies,
we present these data as if from a non-cluster randomised study,
but adjusted for the clustering effect.
We have sought statistical advice and have been advised that the
binary data as presented in a report should be divided by a ’design
effect’. This is calculated using the mean number of participants
per cluster (m) and the intraclass correlation coefficient (ICC)
[Design effect =1+(m-1)*ICC] (Donner 2002). If the ICC was
not reported it was assumed to be 0.1 (Ukoumunne 1999).
If cluster studies had been appropriately analysed, taking into ac-
count intraclass correlation coefficients and relevant data docu-
mented in the report, synthesis with other studies would have been
possible using the generic inverse variance technique.
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2. Cross-over trials
A major concern of cross-over trials is the carry-over effect. It oc-
curs if an effect (e.g. pharmacological, physiological or psycho-
logical) of the treatment in the first phase is carried over to the
second phase. As a consequence, on entry to the second phase
the participants can differ systematically from their initial state
despite a wash-out phase. For the same reason cross-over trials are
not appropriate if the condition of interest is unstable (Elbourne
2002). As both effects are very likely in severe mental illness, we
will only use data of the first phase of cross-over studies.
3. Studies with multiple treatment groups
Where a study involvedmore than two treatment arms, if relevant,
we have presented the additional treatment arms in comparisons.
Where the additional treatment arms were not relevant, we have
not reproduced these data.
Dealing with missing data
1. Overall loss of credibility
At some degree of loss of follow-up data must lose credibility (Xia
2007). For any particular outcome, should more than 50% of data
be unaccounted for, we did not reproduce these data or use them
within analyses. If, however,more than 50% of those in one arm of
a study were lost, but the total loss was less than 50%, we marked
such data with (*) to indicate that such a result may well be prone
to bias.
2. Binary
In the case where attrition for a binary outcome is between 0%
and 50% and where these data were not clearly described, we have
presented data on a ’once-randomised-always-analyse’ basis (an in-
tention-to-treat analysis). We assumed that those leaving the study
early had the same rates of negative outcome as those who com-
pleted, with the exception of the outcome of death. We under-
took a sensitivity analysis testing how prone the primary outcomes
were to change when ’completed’ data only were compared to the
intention-to-treat analysis using the above assumption.
3. Continuous
3.1 Attrition
In the case where attrition for a continuous outcome is between
0% and 50% and completer-only data were reported, we have
reproduced these.
3.2 Standard deviations
We first tried to obtain the missing values from the authors. If
not available, where there were missing measures of variance for
continuous data but an exact standard error and confidence inter-
val were available for group means, and either P value or T value
were available for differences in mean, we calculated them accord-
ing to the rules described in the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2009). When only the standard
error (SE) is reported, standard deviations (SDs) are calculated by
the formula SD =SE * square root (n). Chapters 7.7.3 and 16.1.3
of the Handbook (Higgins 2009) present detailed formula for es-
timating SDs from P values, T or F values, confidence intervals,
ranges or other statistics. If these formulae do not apply, we calcu-
lated the SDs according to a validated imputationmethodwhich is
based on the SDs of the other included studies (Furukawa 2006).
Although some of these imputation strategies can introduce error,
the alternative would be to exclude a given study’s outcome and
thus to lose information. We nevertheless examined the validity of
the imputations in a sensitivity analysis excluding imputed values.
3.3 Last observation carried forward
We anticipated that in some studies themethod of last observation
carried forward (LOCF) would be employed within the study
report. As with all methods of imputation to deal with missing
data, LOCF introduces uncertainty about the reliability of the
results. Therefore, where LOCF data have been used in the trial, if
less than 50% of the data have been assumed, we reproduced these
data and indicated that they are the product of LOCFassumptions.
Assessment of heterogeneity
1. Clinical heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge clinical heterogeneity. We simply inspected
all studies for clearly outlying situations or people which we had
not predicted would arise. When such situations or participant
groups arose, we fully discussed these.
2. Methodological heterogeneity
We considered all included studies initially, without seeing com-
parison data, to judge methodological heterogeneity. We simply
inspected all studies for clearly outlying methods which we had
not predicted would arise. Should such methodological outliers
arise, we will fully discuss these.
3. Statistical heterogeneity
3.1 Visual inspection
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We visually inspected graphs to investigate the possibility of sta-
tistical heterogeneity.
3.2 Employing the I2 statistic
We investigated heterogeneity between studies by considering the
I2 method alongside the Chi2 P value. The I2 provides an estimate
of the percentage of inconsistency thought to be due to chance
(Higgins 2003). The importance of the observed value of I2 de-
pends on i. magnitude and direction of effects and ii. strength
of evidence for heterogeneity (e.g. P value from Chi2 test, or
a CI for I2). We interpreted I2 estimate greater than or equal
to 50% accompanied by a statistically significant Chi2 statistic,
as evidence of substantial levels of heterogeneity (Section 9.5.2 -
Higgins 2009).When we found substantial levels of heterogeneity
in the primary outcome, we explored reasons for heterogeneity
(Subgroup analysis and investigation of heterogeneity).
Assessment of reporting biases
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results (Egger 1997).
These are described in Section10of theHandbook (Higgins 2009).
We are aware that funnel plots may be useful in investigating
reporting biases but are of limited power to detect small-study
effects.We did not use funnel plots for outcomes where there were
10 or fewer studies, or where all studies were of similar sizes. In
other cases, where funnel plots were possible, we sought statistical
advice in their interpretation.
Data synthesis
Where possible we employed a random-effects model for analyses.
We understand that there is no closed argument for preference for
use of fixed-effect or random-effects models. The random-effects
method incorporates an assumption that different studies are esti-
mating different, yet related, intervention effects. According to our
hypothesis of an existing variation across studies, to be explored
further in the meta-regression analysis despite being cautious that
random-effects methods does put added weight onto the smaller
of the studies - we favoured using random-effects model.
Subgroup analysis and investigation of heterogeneity
1. Subgroup analyses
We did not plan a subgroup analysis. However, we did undertake
one for discontinuation of treatment due to satisfaction with care,
adverse events or costs of care.
2. Investigation of heterogeneity
If inconsistency was high, we have reported this. First we inves-
tigated whether data had been entered correctly. Second, if data
had been correct, we visually inspected the graph and successively
removed studies outside of the company of the rest to see if hetero-
geneity was restored. Should this occur with no more than 10% of
the data being excluded, we have presented data. If not, we have
not pooled data and have discussed relevant issues.
Should unanticipated clinical or methodological heterogeneity be
obvious, we simply stated hypotheses regarding these for future
reviews or versions of this review. We did not anticipate undertak-
ing analyses relating to these.
Sensitivity analysis
1. Implication of randomisation
We aimed to include trials in a sensitivity analysis if they were
described in some way as to imply randomisation. For the primary
outcomes we included these studies and if there was no substan-
tive difference when the implied randomised studies were added
to those with better description of randomisation, then we have
employed all data from these studies.
2. Assumptions for lost binary data
Where assumptions had to be made regarding people lost to fol-
low-up (Dealing with missing data), we compared the findings of
the primary outcomes when we used our assumption compared
with completer data only. If there was a substantial difference, we
reported results and discuss them but continue to employ our as-
sumption.
Where assumptions had to be made regarding missing SDs data
(Dealing withmissing data), we compared the findings on primary
outcomes when we used our assumption compared with complete
data only. We undertook a sensitivity analysis testing how prone
results were to change when ’complete’ data only were compared
to the imputed data using the above assumption. If there was
a substantial difference, we have reported results and discussed
them, but continue to employ our assumption.
3. Published and unpublished data
We included both published and unpublished data and separated
them in the sensitivity analysis. If there was no substantive dif-
ference when the unpublished data were added to the data from
published trials, then we employed all data from these studies.
R E S U L T S
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Description of studies
Please see Characteristics of included studies, Characteristics
of excluded studies, and Characteristics of studies awaiting
classification.
Results of the search
The 2010 update search identified 162 references (from 124
studies). Agreement about which reports may have been ran-
domised was total and we selected and ordered 55 of the orig-
inal reports. One of these reports is a new study to this review
(Kallert-EU-2007) and two have been added to those awaiting
assessment (Donnison 2001; Gjonbalaj-Marovic 2005). Four re-
ports were additional references to already included studies (Figure
1).
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Figure 1. Study flow diagram - 2010 update
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Included studies
The current review includes 46 reports describing 10 stud-
ies (Creed-UK-1990; Creed-UK-1996; Dick-UK-1985; Herz-
US-1971; Kallert-EU-2007; Kris-US-1965; Schene-NL-1993;
Sledge-US-1996; Wiersma-NL-1989; Zwerling-US-1964). This
review now includes data on 2685 randomised people fromwithin
these 10 separate trials.
1. Methods
All studies were stated to be randomised. Sledge-US-1996, how-
ever, once people were randomised, would give the other treatment
package if the treatment of allocation was not available. None of
the 10 trials used evaluators who were blind to group allocation,
but eight used people to rate outcome who were independent of
the trialists and carers. In Kris-US-1965 and Schene-NL-1993, it
was unclear if the evaluators were independent. For further details
please see Risk of bias in included studies (sections on Allocation
and Blinding).
2. Design
2.1 Pre-randomisation exclusions vs everyone randomised
We found included trials to be of two types. Type 1 trials excluded,
before randomisation, any who were considered ineligible for day
hospital treatment (for example, people who were too violent
or under compulsion). The Type 1 trials were Creed-UK-1990,
Creed-UK-1996, Dick-UK-1985, Herz-US-1971, Kallert-EU-
2007, Kris-US-1965, Schene-NL-1993, Sledge-US-1996. Type 2
trials randomised everyone presenting for admission regardless of
suitability, but admitted to the inpatient ward any people allo-
cated to day hospital who were too unwell for immediate day hos-
pital treatment. The Type 2 trials were Wiersma-NL-1989 and
Zwerling-US-1964.Themethodological differences betweenType
1 and Type 2 trials meant that it would not have been sensible to
analyse in the same comparison.
3. Duration
The follow-up periods of the trials were: 2 months (Kris-US-
1965); 6 months (Schene-NL-1993); 10 months (Sledge-US-
1996); 12 months (Creed-UK-1990; Creed-UK-1996; Dick-
UK-1985; Kallert-EU-2007); and 24 months (Herz-US-1971;
Wiersma-NL-1989; Zwerling-US-1964). In two trials (Kallert-
EU-2007; Sledge-US-1996) the follow-up period began on dis-
charge from inpatient/day patient care, whereas in the others it
began on the day of randomisation.
4. Participants
Participants now total 2685 people. These were both men and
women, mostly aged between 30 and 50 years of age, with diag-
noses of various acute psychiatric disorders, butmainly schizophre-
nia and mood disorders. Only Kallert-EU-2007 reported a pre-
trial power calculation. The trials in descending order of size were:
Kallert-EU-2007 (1117); Zwerling-US-1964 (378); Schene-
NL-1993 (222); Sledge-US-1996 (197); Creed-UK-1996 (187);
Wiersma-NL-1989 (160); Kris-US-1965 (141); Creed-UK-1990
(102); Dick-UK-1985 (91) and Herz-US-1971 (90).
5. Setting
All trials except Wiersma-NL-1989 recruited from a population
whowould otherwise have been admitted to a general adult psychi-
atricward.Two trials tookplace in the same day hospital in an inner
city area of Manchester, UK (Creed-UK-1990; Creed-UK-1996).
In the earlier trial, eligible patients were voluntary patients who
were not too ill for day care, and who had no social factors that
made day care impractical (such as being of no fixed abode). In
addition to these criteria, the later trial excluded patients with
organic brain disease or mania. Dick-UK-1985 took place in an
acute day hospital in Dundee, Scotland. Patients were excluded if
day hospital treatment was judged impractical or they were con-
sidered too ill or suicidal. Herz-US-1971 took place in an acute
day hospital in New York State, USA. Patients were excluded if
day care was judged impractical or if they were considered too
ill or too well for day care. Kallert-EU-2007 was a multi-centre
study with five sites: Dresden, Germany; London, UK; Wroclaw,
Poland; Michalovce, Slovak Republic; and Prague, Czech Repub-
lic. Patients were included if they were in need of acute admis-
sion to a psychiatric facility and excluded if it was an involun-
tary admission, they lived too far from the hospital or were home-
less, acute intoxication, addictive disorder, or required inpatient
care. Kris-US-1965 took place in an acute day hospital in New
York, USA. Patients were eligible if they had had a previous ad-
mission for a psychotic disorder. Schene-NL-1993 took place in
an acute day hospital at the University of Utrecht, Netherlands.
Patients were excluded if there were contraindications to day hos-
pital treatment (not specified) or they had organic brain disease
or a primary diagnosis of substance abuse or mental retardation.
Sledge-US-1996 took place at a community mental health centre
day hospital in New Haven, Connecticut, USA. The day hospital
was closely linked to a crisis residence run by a non-profit organi-
sation. Patients were excluded if they were; involuntary, not living
locally, too ill for day patient treatment, intoxicated, or physically
unwell. Wiersma-NL-1989 took place in a day hospital operated
by the Regional Institute for Ambulatory Mental Health Care in
Groningen, Netherlands. All patients presenting for inpatient care
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were included in the trial except for forensic patients on court or-
ders and patients with dementia. No prior assessment was made of
suitability for day hospital treatment. Patients randomised to day
hospital treatment who were too unwell for immediate transfer
were treated as inpatients but transferred to day hospital care as
soon as feasible. Zwerling-US-1964 took place in a day hospital
in New York, USA.
6. Interventions
In Creed-UK-1990, eight nurses and three occupational therapists
staffed the day hospital with input from three consultant psychi-
atrists. In Creed-UK-1996, the day hospital had similar staffing
levels to Creed-UK-1990, but there was additional input from a
community psychiatric nurse (who could visit patients who failed
to turn up for treatment) and an out of hours on-call service for
day patients. In Dick-UK-1985 the day hospital was staffed by
two trained staff and an occupational therapist and had a staff-
patient ratio of 1:12.5. The day hospital offered individual coun-
selling, groups, activities and medication. In Herz-US-1971 the
day hospital offered group-oriented psychotherapy; staffing levels
were not reported. In Kallert-EU-2007 the day hospitals provided
between 15 and 35 places, with mean staff hours per week per
treatment place ranging from 8.8 to 16.0. General clinical exper-
tise was high in all centres.Within the centres, the day hospital and
inpatient settings varied, but not systematically. In the Dresden
day hospital they specialised in outreach activities and vocational
rehabilitation, and in Wroclaw there were similar differences; in
London “psychological interventions” for inpatients were limited
to supportive talks; in Wroclaw and Michalovce there was a low
level of general hospitals. In Prague, the there were no differences
between the settings. In Kris-US-1965, the day hospital offered
milieu and group therapy; staffing levels were not reported. In
Schene-NL-1993, the day hospital offered psychosocial therapy
and had a staff:patient ratio of 1:12.5. In Sledge-US-1996, the
day hospital was a 20-patient facility staffed by doctors, nurses,
social workers and other therapists. Treatment emphasised group
work, control of symptoms and improvement in daily living skills.
The day hospital was linked to a crisis residence, which was a
three-bedroom apartment supported by a crisis respite unit. In
Wiersma-NL-1989, the day hospital was supported by integrated
ambulatory and domiciliary care and by a back-up bed on the
inpatient ward. A 24-hour telephone help-line was available to all
day hospital patients. The day hospital offered amulti-disciplinary
treatment programme, but staffing levels were not reported. In
Zwerling-US-1964, the day hospital offered group-oriented activ-
ities and family therapy for up to 30 patients. Staffing consisted
of four full-time nurses, four nurse’s aides, a clinical psychologist,
a social worker and dedicated time from senior and junior psychi-
atrists.
7. Outcomes
7.1 Intention-to-treat analysis
Schene-NL-1993 and Zwerling-US-1964 were not carried out
on an intention-to-treat basis (see Risk of bias in included studies
below) and so reported data on feasibility only. We did not seek
individual patient data for these trials as they could not be analysed
on an intention-to-treat basis. Kallert-EU-2007 was intention-to-
treat, although we did not seek individual patient data for this
trial.
7.2 Individual patient data
We sought these for seven other trials and obtained them for four
(Creed-UK-1990; Creed-UK-1996; Sledge-US-1996; Wiersma-
NL-1989). These individual patient data covered 646 patients.
Of the three remaining trials, contact with the trialists confirmed
that individual patient data were no longer available for Dick-UK-
1985 or Herz-US-1971. We were unable to locate the trialists for
Kris-US-1965.
7.3 Missing outcomes
After taking individual patient data into account, trials provided
useable data on all the outcomes defined under ’Types of outcome
measures’ above.
7.4 Continuous outcomes
Wehave provided details of the scales that supplied useable data for
this review below. We have provided reasons for exclusion of data
from other scales in the ’Outcomes’ column of the Characteristics
of included studies tables.
a. Mental state
i. Present State Examination (Wing 1972)
This was used inCreed-UK-1990 andWiersma-NL-1989. This is
a clinician-rated scale measuring mental status. One hundred and
forty symptom items are rated and combined to give various syn-
drome and sub-syndrome scores. Higher scores indicate increased
severity of psychiatric symptoms.
ii. Comprehensive Psychopathology Rating Scale (Asberg 1978)
This was used in Creed-UK-1996. A four-point scale is used to
rate 40 items, and 25 items are rated by observation using the same
scale. Global rating of the illness is an additional item. Higher
scores indicate increased severity of psychiatric symptoms.
iii. Brief Psychopathology Rating Scale (BPRS, Overall 1962)
This was used in Kallert-EU-2007 and Sledge-US-1996. A brief
rating scale used to assess the severity of a range of psychiatric
symptoms, including psychotic symptoms. The scale has 16 items,
and each item can be defined on a seven-point scale varying from
’not present’ (0) to ’extremely severe’ (6).
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iv. Clinical Interview Schedule (Goldberg 1972)
This was used in Dick-UK-1985. Scoring method is unclear in
this particular trial, “twice the sum of the mental state ratings was
added to the sum of the symptom ratings to give an overall sever-
ity score”. Higher scores indicate increased severity of psychiatric
symptoms.
b. Social functioning
i. Social Behaviour Assessment Schedule (Platt 1981)
This was used in Creed-UK-1990 & Creed-UK-1996. This scale
yields scores in three areas: social role performance (used here),
abnormal behaviours (not used) and burden on relatives (used
below). Higher scores indicate greater social dysfunction.
ii. Social Adjustment Schedule (SAS, Weissman 1981)
This was used in Sledge-US-1996. Measures social functioning in
a number of life domains (work, social, extended family, marital,
parental, family unit and economic adequacy) on a scale of 1-7.
Lower scores indicate poorer functioning.
iii. Groningen Social Disabilities Schedule (Wiersma 1988)
This was used in Wiersma-NL-1989. Rated on a scale of 0 to 4,
with higher scores indicating greater social disability.
iv. Groningen Social Disabilities Schedule, Second Revision
(GSDS II, Wiersma 1990)
This was used in Kallert-EU-2007. Rating are assigned for nine
different social roles and for each dimension of the role. The sum
score is based on overall role ratings, from 0 (’no disability’) to 3
(’severe disability’).
c. Burden on relatives
i. Social Behaviour Assessment Schedule (burden sub-scale, Platt
1981)
This was used in Creed-UK-1990. This is a large structured in-
terview-based (329 questions) instrument to assess disturbed be-
haviour, social performance and burden on household/home/in-
stitute personnel. Extensive training is needed and the adminis-
tration of the SBAS takes approximately one hour. The burden
section has been used on its own and the 35 items are always ap-
plicable to all participants; it is the score of these items that is
often used for comparative studies. All items are to be scored 0-
3 (no distress, distress, resignation). The time window is at least
one month. The SBAS score is higher in lower-class families and
increases with duration of illness.
d. Treatment satisfaction
i. Client Assessment of Treatment (CAT, Priebe 1995)
This was used in Kallert-EU-2007. This questionnaire comprises
seven 11-point visual analogue rating scales, which ranged from
(’not at all satisfied’) to 10 (’yes, entirely satisfied’).
e. Quality of life
i. Manchester Short Assessment of Quality of Life (MANSA,
Oliver 1996)
This was used in Kallert-EU-2007. This is a modified version
of the Lancashire Quality of Life Profile consisting of subjective
ratings of satisfaction with life as a whole and with specific life
domains. The rating scale on each item ranged from 1 (’could not
be worse’) to 7 (’could not be better’).
Excluded studies
In the first version of this review we excluded 64 studies. In the
latest version, we have excluded a further three studies from the
review. One was not randomised (Dal Santo 2004), one was a
systematic review (Shek 2009) and one did not test day hospital
care as the intervention (Davidson 2006).
8. Awaiting classification
One trial, in the German language, is awaiting translation (Vietze-
Germany).
Risk of bias in included studies
We prepared a risk of bias assessment for each trial. For multi-
centre trials providing data for single centres, we did not assess the
risk of bias for each centre. Our judgments regarding the overall
risk of bias in individual studies is illustrated in Figure 2 and Figure
3.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
Of the 10 trials analysed in this review, five reported an adequate
generation of allocation sequence, one trial did not have an ade-
quate sequence generation (Sledge-US-1996) and the method of
assignment was unclear in the remaining studies. Similarly, the
methods used to conceal allocation were reported as adequate in
four trials and unclear in the remaining studies.
Blinding
Blinding of participants, care providers, or outcome assessors was
not possible in any of the trials due to the nature of the interven-
tions.
Incomplete outcome data
Incomplete datawas addressed in one of the 10 studies, was unclear
in four studies, and was not addressed adequately in the remaining
trials.
Selective reporting
Five studies were free from selective reporting. In all the trials
except Kallert-EU-2007, it was unclear whether they were free
from other biases.
Other potential sources of bias
1. Individual patient data
No substantial discrepancies were noted between the summary
data in published reports and the summary data calculated from
individual patient data, thus indicating that the correct data sets
had been obtained.
2. Changes in the nature of day hospital treatment
It was noted that in four of the more recent trials, day hospital
care was augmented by sleep-over facilities (Sledge-US-1996) or
outreach services (Creed-UK-1996; Kallert-EU-2007; Wiersma-
NL-1989). This suggests that day hospital practicemay be evolving
over time and so it is recommended that trials are viewed sorted
by year in analyses.
Effects of interventions
See:Summaryof findings for themain comparisonDayhospital
compared to Inpatient for acute psychiatric disorders
For methodological reasons it was necessary to carry out separate
comparisons for Type 1 and Type 2 trials (see Description of
studies).
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1. Comparison: day patient versus inpatient care for
Type 1 trials
1.1 Feasibility and engagement
1.1.1 Proportion of patients suitable for day patient care
We defined the feasibility of day treatment as the percentage re-
duction in acute inpatient admissions that could be achieved by
diverting patients to an acute day hospital (see Methods above).
Table 1 summarises the data on the proportion of patients suit-
able for day hospital treatment. The combined optimistic estimate
of feasibility was 37.5% (n = 1768 CI 35.2 to 39.8), whilst the
combined pessimistic estimate was 23.2% (n = 2268 CI 21.2 to
25.2). Kallert-EU-2007 reported that 8% to 16% of day hospital
patients across the study sites had to be transferred to inpatient
settings for clinical reasons.
1.1.2 Number lost to follow-up
Seven trials (Creed-UK-1990; Creed-UK-1996; Dick-UK-1985;
Herz-US-1971; Kallert-EU-2007; Schene-NL-1993; Sledge-US-
1996) reported data on number lost to follow-up (Analysis 1.1),
showing no difference between day hospital and control groups
at three months (1 RCT, n = 1117, RR 0.97 CI 0.80 to 1.17),
six months (2 RCTs, n = 312, RR 0.83 CI 0.58 to 1.19) and
12 months (5 RCTs, n = 1694, RR 0.94 CI 0.82 to 1.08). The
pooled results for follow-up of six months and 12 months, how-
ever, showed evidence of heterogeneity (I2 = 64% and I2 = 45%
respectively). Analysis by year of publication suggested a time de-
pendent effect, with earlier trials having a higher dropout rate in
the day hospital group and later trials having either a similar or a
lower drop out rate in the day hospital group.
1.2 Extent of hospital care
1.2.1 Duration of index admission
Four trials (Creed-UK-1990; Creed-UK-1996; Kallert-EU-2007;
Sledge-US-1996) reported data that permitted calculation of the
duration of index admission (defined as time from first admis-
sion to discharge to outpatient care) (Analysis 1.2); in three of
these studies individual patient datawas provided from the authors
(Creed-UK-1990;Creed-UK-1996; Sledge-US-1996). These data
showed that patients randomised to day hospital care had a signif-
icantly longer index admission (4 RCTs, n = 1582, WMD 27.47
CI 3.96 to 50.98). There was, however, high heterogeneity (I2 =
91%), which was attributable to differences between the three EU
trials (where day patient was significantly longer than in patient
stay), and the US trial (where day patient was shorter than in-
patient stay). Two further trials (Dick-UK-1985; Herz-US-1971)
also reported data on duration of index admission, but in a form
that could not be included in the meta-analysis (Analysis 1.3).
1.2.2 Days in inpatient or day patient care
The use of hospital care throughout the study was assessed using
individual patient data from three trials (Creed-UK-1990; Creed-
UK-1996; Sledge-US-1996) (Analysis 1.4). These data showed no
difference in total number of days in hospital between day hospital
patients and controls (3 RCTs, n = 465, WMD -0.38 days/month
CI -1.32 to 0.55). However, further analyses of these data showed
that, compared to controls, patients randomised to day hospital
care spent significantly more days in day hospital care (3 RCTS,
n = 265, WMD 2.34 days/month CI 1.97 to 2.70; Analysis 1.5)
and significantly fewer days in inpatient care (3 RCTs, n = 265,
WMD -2.75 days/month CI -3.63 to -1.87; Analysis 1.6).
1.2.3 Readmitted to in/day patient care after discharge
Five trials reported data on number of patients readmitted to
hospital care (either inpatient or day hospital) after discharge
from the index admission (Creed-UK-1990; Creed-UK-1996;
Dick-UK-1985; Herz-US-1971; Sledge-US-1996). These data
showed no significant difference between day hospital and control
groups (n = 667, RR 0.91 CI 0.72 to 1.15) (Analysis 1.7).
1.3 Clinical and social outcomes
Three trials (Creed-UK-1990; Creed-UK-1996; Sledge-US-1996,
total n = 486) provided individual patient data onmental state and
social functioning at various time points. Although the trials dif-
fered in the choice of questionnaire instruments and time points
for follow-up data collection (Table 2), it was possible to combine
the individual patient data from the trials. Table 3 gives a break-
down of demographic characteristics of patients from these trials.
Forty-two (8.6 %) people had to be dropped from the statistical
modelling of outcome due to incomplete covariate data. These ap-
pear to be evenly distributed between intervention groups (Table
3). No data were available on quality of life, though one trial had
used an unpublished quality of life scale (Sledge-US-1996).
1.4 Mental state (at various time points)
Due to absence of follow-up mental state data, we were unable to
include a further 37 patients (7.6%) in this analysis. These were
divided between as follows: seven from Creed-UK-1990 (five in-
patients and two day patients), seven from Creed-UK-1996 (five
inpatients and two day patients) and 23 from Sledge-US-1996 (16
inpatients and seven day patients). There was evidence of curva-
ture of the profiles and positive skew, so we used a square root
transformation. The square root transformed profiles were more
linear and the patient and time-point level residuals less skewed.
There was evidence of both a significant random intercept (Chi2
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= 180.25, P < 0.001) and a significant random slope effect (Chi2
= 25.46, P < 0.001) measured by change in log-likelihood, so we
included both these terms in the statistical modelling. When a full
model including time-treatment interaction was compared with
a reduced model without the interaction, there was evidence of a
significant time-treatment interaction measured by change in log
likelihood (Chi2 = 9.66, P = 0.002). The difference in slope was
-0.007 (CI -0.011 to -0.002) with the negative coefficient repre-
senting increased improvement in the day hospital group (Table
4).The intervention group had a significant effect (Chi2 = 4.58,
P = 0.032), indicating a difference in baseline levels for the two
groups. The difference was 0.144 (CI 0.009 to 0.278), represent-
ing a higher baseline for the day hospital group. To ensure that
this difference was not causing the difference in slope, we repeated
the analysis without this term so forcing a common baseline to
be modelled. The overall conclusion did not alter, indicating that
the differing baseline values were not causing the significant dif-
ference between slopes. None of the other covariates had a sig-
nificant effect. Unfortunately it is not possible to estimate the
extent of the difference in improvement rates, as back transfor-
mation of square-root transformed data is not easily interpreted.
Dick-UK-1985 (which did not provide individual patient data)
also measured mental state using the Clinical Interview Schedule
(Goldberg 1972) at 0.75, four and 12 months. No standard devi-
ations were provided, but a significant difference in favour of day
hospital treatment was reported at 0.75 months, but not at the
other time points (decrease in score: 0.75 ms DP 13.6 IP 9.6, P <
0.001 T test; 4ms DP 16.2 IP 11.6, P = ns; 12 ms DP 20 IP 14.1,
P = ns).
1.4.1 Mental state: average endpoint score (BPRS,
high=poor)
One trial reported data for mental state (Analysis 1.8) and found
that day hospital care was not superior to inpatient care in im-
proving mental state at discharge (n 1 117, MD -0.01 CI -0.07 to
0.05), at three months (n = 1117, MD -0.05 CI -0.11 to 0.01) and
at 12 months (n = 1117, MD -0.05 CI -0.11 to 0.01). At admis-
sion, the mental state of day hospital patients was more favourable
than inpatients (n = 1117, MD -0.08 CI -0.13 to -0.03).
1.5 Social functioning (at various time points)
Due to absence of follow-up social functioning data, we were un-
able to include 149 patients (30.6%) from Type 1 trials in the
analysis of data. These were divided between the studies as follows:
15 fromCreed-UK-1990 (nine inpatients and six day patients); 83
from Creed-UK-1996 (43 inpatients and 40 day patients); and 51
from Sledge-US-1996 (32 inpatients and 19 day patients). There
was evidence of a significant random intercept (Chi2 = 62.58, P <
0.001), but no significant random slope effect (Chi2 = 0.80, P =
0.67) measured by change in log-likelihood, so only the random
intercept was included in the statistical modelling. When a full
model, including time-treatment interaction, was compared with
a reduced model without the interaction, there was no evidence of
a time-treatment interaction measured by change in log likelihood
(Chi2 = 0.006, P = 0.941, see Table 5). There was a significant age
(Chi2 = 7.82, P = 0.005) and a significant gender effect (Chi2 =
21.95, P < 0.001), with increased age having a positive effect on
improvement and males improving less.
1.5.1 Social functioning: average overall role score (GSDS-II,
high=poor)
One trial reported data for social functioning (Analysis 1.9) and
found that day hospital care was superior to inpatient care in im-
proving social functioning at admission (n = 1117, MD -0.13 CI
-0.20 to -0.06), at discharge (n = 1117, MD -0.34 CI -0.48 to -
0.20), at three months (n = 1117, MD -0.10 CI -0.19 to -0.01)
and at 12 months (n = 1117, MD -0.11 CI -0.19 to -0.03).
1.6 Burden on carers (at various time points)
Two trials reported data on burden on carers (Creed-UK-1990
- 0, 3 & 12 months; Creed-UK-1996 - 0, 0.5, 1, 2, 3, 6 & 12
months - Analysis 1.10), collected using the SBAS Burden Scale
(Platt 1981). However, we were unable to include data on burden
from Creed-UK-1996 at six and 12 months, as it was available on
less than 50% of randomised people. The available data showed
no difference in carer burden between day hospital and control
groups at two weeks, and one, two three and 12 months, although
there were limited data for all time points except three months
(wheremean difference = -0.59 CI -1.62 to 0.44 i.e. not significant
but favouring day hospital treatment).
1.7 Death (suicide/homicide/all causes)
Herz-US-1971 and Kallert-EU-2007 reported on deaths amongst
participants (Analysis 1.11) and showed no significant difference
between treatment groups (n = 1207, RR 0.18 CI 0.02 to 1.54).
Other deaths were acknowledged in some trials, but these data
were neither reported in relation to group of randomisation, nor
was it possible to derive this information from individual patient
data.
1.8 Employed at end of study
Two Type 1 trials (Creed-UK-1996; Kris-US-1965) reported
number unemployed (Analysis 1.12), and found a significant dif-
ference in favour of day hospital care (2 RCTs, n = 320, RR 0.81,
CI 0.67 to 0.97). Creed-UK-1996 provided this data at 12-month
follow-up. The data for Kris-US-1965 had limitations as they pro-
vided this data on patients two months after discharge, but the
duration of the index admission was not specified. They also re-
ported the percentages of the patients that were employed at the
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end of the study, and as it is unclear the number lost to follow-up
from each group, we calculated the number of patients employed
based on the total number randomised. Kallert-EU-2007 did not
report risk ratios for unemployment, but found that at discharge,
those who not reassessed were significantly more likely to be un-
employed than those who were reassessed (P < 0.001).
1.9 Satisfaction with care (patients and relatives)
Only Dick-UK-1985 reported data on number not satisfied with
care (Analysis 1.13); these data showed a significant difference in
favour of day hospital care (n = 91, RR 0.46 CI 0.27 to 0.79,
NNT 3). One trial provided score data for treatment satisfaction
(Average CAT score, low = poor) (Analysis 1.14) and found that
day hospital care was not superior to inpatient care in improving
treatment satisfaction at admission (n = 1117, MD 0.22 CI -0.04
to 0.48) and at discharge (n = 1117, MD 0.06 CI -0.18 to 0.30).
1.10 Costs of care
Data on costs of care were reported by four trials (three provided
individual patient data) (Analysis 1.15, Analysis 1.16). The four
trials found that day hospital care was cheaper than hospital care
(with eight of eight comparisons across a range of cost indices
favouring day hospital care, six significantly - Analysis 1.16). Re-
ductions in costs ranged from 33.5% to 49.6% for the index ad-
mission, to 20.9% to 36.9% for the costs of all psychiatric care
(including hospital care). Kallert-EU-2007 also measured costs of
care, but this was reported in German. Results from the UK sites
were reported in English and found that mean total support costs
were higher for the day hospital group over the treatment period:
£6523 versus £3619 (bootstrapped 95%CI 375 to 4511). The ob-
served between-group difference for the costs of hospital services
(including all inpatient admissions, day hospital attendance and
outpatient visits) was large but not statistically significant: £4565
versus £3442 (bootstrapped 95% CI -1185 to 2689).
1.11 Quality of life: average overall role score (MANSA,
low=poor)
One trial reported data for quality of life (Analysis 1.17) and found
that day hospital care was not superior to inpatient care in im-
proving social functioning at admission (n = 1117, MD -0.02 CI -
0.13 to 0.09), at discharge (n = 1117, MD 0.01 CI -0.12 to 0.14),
at three months (n = 1117, MD 0.11 CI -0.02 to 0.24) and at 12
months (n = 1117, MD 0.01 CI -0.13 to 0.15).
2. Comparison: day patient versus inpatient care for
Type 2 trials
There were two Type 2 trials (Wiersma-NL-1989; Zwerling-
US-1964). Only one reported data for seven of the outcomes
(Wiersma-NL-1989).
2.1 Feasibility and engagement
2.1.1 Proportion of patients suitable for day patient care
The estimate of feasibility (Table 6) ranged from 18.4% (from
Wiersma-NL-1989, which reported the number of people averag-
ing six or more nights per week away from hospital in the first 15
weeks of the trial) to 39.1% (based on Zwerling-US-1964, a trial
which reported the number of patients treated entirely in the day
hospital without readmission).
2.1.2 Number lost to follow-up
Wiersma-NL-1989 reported data on number lost to follow-up
(Analysis 2.1), showing a significant difference in favour of the
day hospital group (n = 160, RR 0.69 CI 0.48 to 0.99, NNT 6).
2.2 Extent of hospital care
2.2.1 Duration of all hospital care
Wiersma-NL-1989 reported data on the extent of hospital care
(Analysis 2.2); however this was in a format that could not be
easily comparedwith that fromType1 trials even though individual
patient data were available. Rather than reporting days in day
hospital or inpatient care, Wiersma-NL-1989 reported “nights in
hospital” (defined as number of nights spent in hospital during
follow-up) and “nights out of hospital” (defined for the control
group as nights on leave from inpatient care, and for the day
hospital group as number of nights spent at home whilst in day
care). Wiersma-NL-1989 then combined these data to give a total
length of stay in day/inpatient care. Relative to the data fromType
1 trials, the total length of stay as reported by Wiersma-NL-1989
increases the apparent length of day patient care, because there is
no adjustment for the fact that patients do not attend day hospital
every day of the week. Using this method, Wiersma-NL-1989
found no difference in total number of days in hospital between
day hospital patients and controls (n = 160, WMD 1.1 days/
month CI -1.57 to 3.77). These data could not be disaggregated
into days in inpatient care and days in day hospital.
2.2.2 Readmitted to in/day patient care after discharge
Wiersma-NL-1989 also reported data on number of people read-
mitted to hospital care (either inpatient or day hospital) after dis-
charge from the index admission (Analysis 2.3). These data showed
no significant difference between day hospital and control groups
(n = 160, RR 0.93 CI 0.64 to 1.35).
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2.3 Mental state (at various time points)
Wiersma-NL-1989 provided individual patient data on mental
state at 0,12 and 24 months (Analysis 2.4), which showed no
significant difference between treatment and control groups.
2.4 Social functioning (at various time points)
Wiersma-NL-1989 reported data on social functioning (Gronin-
gen Social Disabilities Schedule, Wiersma 1988) at zero, 12 and
24 months (Analysis 2.5). No significant differences were found
between treatment and control groups on either variable at any
time point.
2.5 Death (suicide/homicide/all causes)
Wiersma-NL-1989 found no difference in death rates (Analysis
2.6) between day hospital and control groups (n = 160, RR 0.74,
95% CI 0.17 to 3.18), but confidence intervals were wide.
2.6 Employed at end of study
Wiersma-NL-1989 found no difference in number unemployed
at 24 months (Analysis 2.7) (n = 160, RR 0.95 CI 0.87 to 1.04).
2.7 Costs of care
Wiersma-NL-1989 (IPD provided) found no significant differ-
ence between day and inpatient care in two comparisons, although
the trend favoured inpatient care (Analysis 2.8, Analysis 2.9).
D I S C U S S I O N
Summary of main results
This review updates a previous version (Marshall 2002). A ma-
jor improvement is the addition of a large EU-multicentre trial
(Kallert-EU-2007), which was based on the recommendations of
Marshall 2002 - namely:
1. recognised the need for a multi-centre randomised
controlled trial to show how far the findings from the present
small number of centres can be more widely replicated;
2. made use of the common set of outcome measures used in
this review; and
3. took care to report data on mortality and other untoward
events and quality of life.
The summary below reflects the outcomes chosen for the
Summary of findings for the main comparison, and is considered
the main findings of this review for support of evidence-based de-
cision making.
1. Feasibility and engagement: lost to follow-up by
one year
It is reasonable to assume that there is no difference between day
hospital care and inpatient care for feasibility and engagement;
although the quality of the evidence is moderate there was also a
moderate level of heterogeneity in the pooled data. This is likely
to be because of a single, small trial with very high risk of biased
results favouring the day hospital intervention (Sledge-US-1996).
2. Extent of hospital care: duration of index admission
and duration of day patient care (adjusted
days/month)
There is moderately strong evidence that the duration of index
admission is longer for patients in day hospital care than inpatient
care. The results are highly heterogeneous, which is largely due to
a single study (Sledge-US-1996), which had a high risk of bias and
different results from other included trials. (If this trial is removed
heterogeneity falls - I2 7% - and confidence in the result increases
(MD33.98CI 26.18 to 41.78) but the overall direction and extent
of finding is similar.
3. Extent of hospital care: duration of day patient care
(adjusted days/month)
The quality of the evidence is very low regarding duration of day
patient care (adjusted days/month). The impression is that this
is longer for patients in day hospital care than those in inpatient
care.
4. Extent of hospital care: readmitted to in/day
patient care after discharge
It is reasonable to assume that there is no difference between day
hospital care and inpatient care for the being readmitted to in/day
patient care after discharge, although the quality of evidence so far
is very low.
5. Unemployed (at end of study)
There is some evidence that day hospital is superior to inpatient
care regarding unemployment at the end of the study. However,
the evidence is of low quality as it comes from only two small
studies, both of which had limitations in the study design.
6. Quality of life and treatment satisfaction
It is likely that there is no difference between day hospital care
and inpatient care for quality of life and treatment satisfaction.
The data for this outcome are only from the most recent large
multi-centre trial (Kallert-EU-2007), therefore the quality of the
evidence was rated as moderate.
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Overall completeness and applicability of
evidence
1. Completeness
After taking individual patient data into account, trials provided
useable data on all the outcomes defined under Types of outcome
measures above.
2. Applicability
A limitation in the applicability of the review is an apparent differ-
ence in practice between US and EU day hospitals. Data on dura-
tion of index admission (both IPD data and other aggregate data)
suggests that US acute day hospitals are geared towards intensive
treatment and rapid discharge, whereas EU day hospitals allow a
more gradual tailing off of day care. It is unclear how far this dif-
ference has implications for effectiveness or cost. Inclusion criteria
do not appear to be an important limitation on the applicability
of the review. Generally Type 1 trials used similar explicit inclu-
sion criteria (that exclude involuntary, suicidal or dangerous pa-
tients), with the exceptions of Kris-US-1965 (which contributed
little data to the meta-analysis) and Creed-UK-1996 (which ex-
cluded patients with mania).
A limitation of this review is that, although we have some infor-
mation about costs, a proper cost-effectiveness analysis of day hos-
pital versus inpatient care is missing and would be an important
addition to this review.
Quality of the evidence
Evidence is estimated to be of moderate quality (based on
GRADE). The additional trial, Kallert-EU-2007, was instigated
following the findings of the previous version of this review
(Marshall 2002) and tried to encompass relevant outcomes. This
was an important addition to the review as it increases the con-
fidence in the results for the outcomes for which it contributed
data, although some of the outcomes were measured on different
scales and so could not be pooled. This trial was of very low risk
of bias and carried more weight than the other pooled trials, and
was treated as such when assessing the risk of bias for the mea-
sured outcomes. In terms of allocation concealment, the quality
of included studies was varied; Creed-UK-1990, Creed-UK-1996,
Kallert-EU-2007 and Zwerling-US-1964 were good, but the re-
maining studies were poor. Whilst no trial used evaluators who
were blind to group allocation, due to the nature of the interven-
tions, in all studies for which we obtained individual patient data,
the authors confirmed that evaluations were performed by inde-
pendent evaluators. Follow-up rates were generally sub-optimal,
and were below 80% in all trials providing individual patient data.
The fact that high attrition rates are common to all recent trials
suggests the problem lies in working with an acutely ill study pop-
ulation, rather than reflecting design limitations in any particular
trial. It is, however, feasible that there is a problem common to all
trial design. There was no evidence of a difference in follow-up
rates between treatment and controls in trials providing individ-
ual patient data, so it is unlikely that lower attrition rates would
have had an impact on the findings of this review; however this
possibility cannot be absolutely discounted.
Potential biases in the review process
Significant attempts have been made to avoid bias in the review
process: we sought individual patient data from most studies and
we did not combine data from Type 1 and Type 2 trials. We are
aware that there is still the potential for bias. However, the ad-
ditional trial included was based on the previous version of this
review and took into account in the study design the recommen-
dations of this review. It was not possible to tell if there was publi-
cation bias, as there were only 10 included trials and a funnel plot
is unreliable in this case.
Agreements and disagreements with other
studies or reviews
We do not know of any other relevant quantitative review in this
topic.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence is of moderate quality, and there is reasonable evi-
dence to support the use of day hospital care to reduce inpatient
care whilst improving patient outcome amongst those suitable for
day hospital care, so it is curious that they are not more popular. In
part this may be due to the difficulties in interpreting day hospital
trials, or the fickleness of psychiatric opinion (see introduction).
On the other hand there are three disadvantages of day hospital
treatment that need to be considered.
1. Day hospital treatment does not appear to be as
effective in reducing admission rates as more radical
crisis intervention approaches
For example, Assertive Community Treatment, when used to di-
vert patients from hospital, can achieve a 55% reduction in admis-
sions as against the 23% achieved by day hospitals (see Irving 2010
for a systematic review). However, the fact that acute day hospitals
do not involve radical, and perhaps unsustainable, alternations in
psychiatric practice (Irving 2010) needs to be considered.
25Day hospital versus admission for acute psychiatric disorders (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2. Cost savings achieved by day hospital care are at
best modest
For example, compared with savings of up to 65% reported in
studies of crisis intervention (Marshall 1999), acute day hospital
care (taking a pessimistic estimate) can be expected to achieve a
saving of 4.8% in the costs of acute psychiatric care (calculated
as: cost savings inpatients diverted multiplied by the proportion
of patients diverted, i.e. 20.9 x 0.232, assuming no inpatient beds
were closed).Moreover the cost equationwould appear as yetmore
unfavourable if it were necessary to build the day hospital, rather
than change practice in an existing non-acute day hospital. On the
other hand, so far it has proven difficult to reliably quantify exactly
how much is saved by crisis intervention approaches (Joy 2000).
Moreover, if acute day hospitals proved to be more sustainable
than crisis intervention alternatives, thismightmean that inpatient
beds could actually be closed, thus shifting the cost equation in
favour of day hospital care. Future versions of this review will have
more information about costs as Kallert-EU-2007 reports on costs
in a report written in German, which is yet to be translated.
3. It is not clear where day hospitals fit with other
types of care
The third disadvantage is that whilst more recent trials (Creed-
UK-1996;Kallert-EU-2007; Sledge-US-1996) have enhancedday
hospital care with respite or outreach services, it still remains un-
clear how day hospital care fits together with other types of com-
munity care, such as Assertive Community Treatment or home-
based care.
In summary therefore, the decision to establish an acute day hos-
pital must be made after careful consideration of local problems
and resources. Acute day hospitals are an attractive option in situ-
ations where demand for inpatient care is high and facilities exist
that are suitable for conversion. They are a less attractive option in
situations where the demand for inpatient care is low and where
effective alternatives are already in operation. The inclusion of a
large, multicentre trial (Kallert-EU-2007) has reinforced the find-
ings that day hospital care is as effective as inpatient care in treating
acutely ill psychiatric patients.
Implications for research
1. Methodological implications for research on acute
day hospitals
1.1Amulti-centre randomised controlled trial was called for in the
previous version of this review. This clinical trial was performed
and reinforces the results about feasibility, days in hospital and has
provided unique data on quality of life and treatment satisfaction.
1.2 Although there is data on costs, and we are awaiting the trans-
lation of costs data for Kallert-EU-2007, it is likely that more new
data on cost-effectiveness are needed.
2. New directions for acute day hospital research
2.1 It would be of interest to explore the relative cost effectiveness
of the US and UK approaches to acute day hospital care (rapid
discharge versus gradual discharge).
2.2 It would be interesting to examine why patients’ psychiatric
symptoms appear to recover more rapidly in day care (for example,
does hospital admission actually worsen symptoms of depression
or anxiety?).
2.3 It is important to examine how acute day hospital care can
be most effectively integrated into a modern community based
psychiatric service.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Creed-UK-1990
Methods Allocation: randomised, sealed envelope.
Blindness: no (evaluation by rater independent of treating clinician, not blind to group
allocation).
Follow-up: 3, 12 months follow-up.
Setting: acute day hospital in inner city.
Analysis: intention to treat.
Place: Manchester, UK.
Participants Diagnosis: schizophrenia 23.5%, mood disorder 25.4%, other 51%.
N = 102.
Age: ~ 42 years.
Sex: M 56%, F 44%.
History: acutely ill patients requiring hospital admission, not involuntary patient, not
too ill for day care and no social factors that made day care impractical
Interventions 1. Acute day hospital: 8 nurses, 3 OTs (N = 51).
2. Routine inpatient (N = 51).
Outcomes Lost to follow-up.
Readmitted.
Hospital service outcomes: duration index admission (estimated from IPD), inpatient
& day patient days/month (IPD).
Mental state: PSE (IPD).
Social functioning: SBAS Role (IPD).
Burden on relatives: SBAS Burden (IPD).
Costs of hospital care (estimated from IPD).
Unable to use -
Mental state: Hamilton rating scale (only measured depressive symptoms).
Social behaviour: SBAS behaviour (role functioning used as key indicator of social func-
tioning)
Notes Type 1 trial (IPD obtained).
Loss to follow up: 31%.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly assorted cards in sealed en-
velopes in blocks of six
Allocation concealment (selection bias) Low risk Sealed envelopes.
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Creed-UK-1990 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
Incomplete outcome data (attrition bias)
All outcomes
High risk Day treatment group: 6 could not be
traced, 10 did not attend sufficiently to be
assessed, 6 had to be transferred to inpa-
tient care
Inpatient group: 9 could not be traced, 3
discharged themselves before they could be
fully assessed
Further analyses considered only those pa-
tients who were fully assessed
Selective reporting (reporting bias) Low risk Expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Study was performed with grants
from the National Unit for Psychiatric Re-
search and Development and the Depart-
ment of Health and Social Security
Creed-UK-1996
Methods Allocation: randomised, sealed envelope.
Blindness: no (evaluation by rater independent of treating clinician, not blind to group
allocation).
Follow-up: 0.5, 1, 2, 3, 6, 12 months.
Setting: acute day hospital in inner-city.
Analysis: intention to treat.
Place: Manchester, UK.
Participants Diagnosis: schizophrenia 38.5%, mood disorder 30%, other 31.5%.
N = 187.
Age: mean ~ 38 years.
Sex: M 54.5%, F 45.5%.
History: acutely ill patients presenting for admission at the psychiatric day hospital, not
involuntary patient, not too ill for day care, not admission for detox and no organic
brain disease, personality disorder or mania
Interventions 1. Acute day hospital CPN out of hours (N = 94).
2. Routine inpatient (N = 93).
Outcomes Lost to follow-up.
Readmitted.
Hospital service outcomes: duration index admission (IPD), inpatient & day patient
days/month (IPD).
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Creed-UK-1996 (Continued)
Mental state: CPRS (IPD).
Social functioning: SBAS Role (IPD).
Burden on relatives: SBAS Burden (IPD).
Costs of care (IPD).
Unable to use -
Social behaviour: SBAS behaviour (role functioning used as key indicator of social func-
tioning).
Burden on relatives: GHQ (this is a measure of depression rather than burden, a more
extensive measure of burden from this trial already included (SBAS) - depression in
relatives was not an outcome included in this review
Notes Type 1 trial (IPD obtained).
Loss to follow-up: 23.5%.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly assorted cards in sealed en-
velopes in blocks of six
Allocation concealment (selection bias) Low risk Sealed envelopes opened by an indepen-
dent administrator.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
Incomplete outcome data (attrition bias)
All outcomes
High risk 4 inpatient and 4 day patients were ex-
cluded due to diagnosis or early discharge.
Five inpatients were transferred to the day
hospital because of lack of beds, and 11 day
patients were transferred to the inpatient
unit because they were too ill for the day
hospital
Selective reporting (reporting bias) Low risk Expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Study funded by theDepartment
of Health, the North Western Regional
Health Authority, and the Mental Health
Foundation
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Dick-UK-1985
Methods Allocation: randomised - no further details.
Blindness: no (evaluation by an independent research psychiatrist, not blind to group
allocation).
Follow up: 0, 3, 12 and 52 weeks.
Setting: acute day hospital.
Analysis: intention to treat.
Place: Dundee, UK.
Participants Diagnosis: neurosis, personality disorder, or adjustment reaction.
N = 91.
Age: mean ~ 35 years.
Sex: M 32.4%, F 67.6%.
History: patients admitted as emergencies with neurosis, personality disorder, or adjust-
ment reaction that were suitable for day hospital treatment (excluded if too ill, suicidal,
or day care impractical)
Interventions 1. Acute day hospital: 2 trained staff + OT, patient/staff ratio: 12.5:1, individual coun-
selling, groups, activities and medication (N = 43).
2. Inpatient care: mixed sex and female wards (N = 48).
Outcomes Lost to follow-up.
Readmitted.
Satisfaction with care.
Hospital service outcomes: duration of index admission.
Mental state: CIS.
Cost of index admission.
Unable to use -
Continuing medication at one year (not an outcome for this review - unclear whether
continuing to take medication at one year is a good or bad outcome in this population)
Notes Type 1 trial (contacted but IPD no longer exists).
Lost to follow up: 29.6%.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised. No further details given.
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
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Dick-UK-1985 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 91 patients were enrolled in the study, 64
patients were followed up to one year. Rea-
sons for default were split about equally
between the patient having moved to an
unknown address, and the patient refus-
ing further co-operation. No further details
given
Selective reporting (reporting bias) Low risk Expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Study supported by a grant from
the Health Services Research Committee
of the Chief Scientist, Scottish Home and
Health Department
Herz-US-1971
Methods Allocation: randomised by random number table (candidates admitted to inpatient care,
then evaluated and those eligible for day hospital randomly allocated).
Blindness: no (evaluation by independent research interviewers, not blind to group
allocation).
Follow up: 0.5, 1, 5, 24 months.
Setting: acute day hospital.
Analysis: intention to treat.
Place: New York State, USA.
Participants Diagnosis: schizophrenia 36%, other 64%.
N = 90.
Age: mean ~ 32 years.
Sex: M 41%, F 59%.
History: not too psychiatrically ill for day care, not too psychiatrically healthy for inpa-
tient care
Interventions 1. Acute day hospital: 5 weekdays attendance, 8-4.30pm, group-oriented psychotherapy,
patient/staff ratio not reported (N = 45).
2. Routine inpatient care: staff, setting and activities same for both groups (N = 45)
Outcomes Lost to follow-up.
Deaths.
Readmitted.
Hospital service outcomes: duration of index admission.
Unable to use -
Mental state: Psychiatric Evaluation Form, Psychiatric Status Schedule (no summary
data)
39Day hospital versus admission for acute psychiatric disorders (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Herz-US-1971 (Continued)
Notes Type 1 trial (contacted, but IPD no longer exists).
Lost to follow up: 18.8%.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers.
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
Incomplete outcome data (attrition bias)
All outcomes
High risk At each follow-up period, the number of
patients actually evaluated was fewer than
the 45 who were in each group (“The
two- and four-week cross-section evalua-
tions were not done on the first 13 pa-
tients”; some could not be interviewed:
“out of town”; “could not be located”; “re-
fused to be interviewed”; “patient no longer
in therapy with [the resident]”). No further
details given
Selective reporting (reporting bias) High risk Not all expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Source of funding not reported
Kallert-EU-2007
Methods Allocation: randomised, opaque, sealed envelopes.
Blindness: no (evaluation by researchers independent of treating clinicians, not blind to
group allocation).
Follow up: 0, 3, 12 months.
Setting: day hospitals in 5 centres.
Analysis: intention to treat.
Place:Dresden,Germany; London,UK;Wroclaw, Poland;Michalovce, SlovakRepublic;
and Prague, Czech Republic
Participants Diagnosis: schizophrenia 26%, mood disorder 33%, other 33%.
N = 1117.
Age: mean ~ 38 years.
Sex: M 44%, F 56%.
History: presented with a mental disorder that had disturbed at least 1 area of daily
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Kallert-EU-2007 (Continued)
living or jeopardised the residential, financial or occupational status of the patient or
their family, other treatments inadequate
Interventions 1. Acute day hospital: provided between 15 and 35 places, mean staff hours per week
per treatment place ranged from 8.8 to 16.0. Staff patient ratios not reported (N = 596)
.
2. Routine inpatient care (N = 521).
Outcomes Lost to follow-up.
Mean duration of admission.
Mental state: BPRS.
Social functioning: GSDs-II.
Treatment satisfaction: CAT.
Quality of life: MANSA.
Notes Type 1 trial.
Loss to follow up: 31.9%.
3 suicides occurred in the inpatient group, it is assumed that these represent all deaths
in this study.
Funding: NHS Executive.
The study has joined a European multi-centred project evaluating similar services in
Prague (Czech Republic), Dresden (Germany),Wroclaw (Poland), and Michalovce (Slo-
vakia)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A computerized random-number genera-
tor created an allocation sequence”
Allocation concealment (selection bias) Low risk “Opaque, sealed envelopes”.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk “The initial attrition rates from random-
ization to admission varied significantly
among settings and centres, with rates for
the total sample of 7.9% for those allocated
to day hospitals and 1.5% for those allo-
cated to day hospitals”; “follow-up rates for
the total sample assessed at admission were
87.0% at discharge, 76.5% 3 months after
discharge, and 68.1% 12 months after dis-
charge”. Missing values were imputed
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Kallert-EU-2007 (Continued)
Selective reporting (reporting bias) Low risk Expected outcomes reported.
Other bias Low risk Study supported by the European Commi-
sion (Quality of life and Management of
Living Resources Programme: QLG4-CT-
2000-01700). Support for travel and ac-
commodation for EDEN project meetings
provided by Pfizer Pharmaceutical Co
Kris-US-1965
Methods Allocation: randomised at time of relapse.
Blindness: no.
Follow up: 2 months after discharge.
Setting: acute day hospital.
Analysis: intention to treat.
Place: New York, USA.
Participants Diagnosis: not reported, but all had suffered from “psychosis”.
Inclusion criteria: previously treated in hospital for psychotic symptoms.
N = 141.
Age: mean unknown.
Sex: F unknown, M unknown.
History: ethnic minority % unknown, married % unknown, unemployed % unknown,
mean previous admissions % unknown
Interventions 1. Acute day hospital: weekdays, 9-5pm, patient/staff ratio not reported, emphasis on
milieu & group therapy (N = 71).
2. Standard inpatient treatment (N = 70).
Outcomes Employed.
Unable to use -
Hospital service outcomes: days in hospital (mean, SD not reported).
Mental state: Wittenborn rating scale (no data reported).
Notes Type 1 trial (unable to contact).
Lost to follow up: not clear.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomly selected, no further details
given.
Allocation concealment (selection bias) Unclear risk No information provided.
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Kris-US-1965 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information provided.
Selective reporting (reporting bias) High risk Not all expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Source of support not reported
Schene-NL-1993
Methods Allocation: randomised - no further details, but 14 later withdrawn because of “incorrect
randomisation”.
Follow up: at 6 months following discharge.
Evaluation: unclear if raters independent of treating clinicians, not blind.
Analysis: not intention to treat, see notes.
Lost to follow up: not clear given exclusions.
Setting: Acute day hospital at the University of Utrecht, Netherlands
Participants Diagnosis: precise estimate not possible because of post-randomisation exclusions.
N = 222.
Age and sex: uncertain given the exclusions post-randomisation.
History: referred for inpatient treatment, no organic brain disease, no primary diagnosis
or substance abuse or mental retardation, no other contraindications to day treatment
Interventions 1. Acute day hospital: staff patient ratio 1:12.5, emphasis on psychosocial therapy (N =
99).
2. Standard inpatient care: University psychiatric clinic (N = 123)
Outcomes Lost to follow-up.
Unable to use -
Hospital Service Outcomes: days in hospital (not an intention-to-treat analysis).
Mental state: PSE, SCL-90 (not an intention-to-treat analysis).
Social Functioning: Groningen Social Disabilities Schedule, Social Network and Social
Support Questionaire (not an intention-to-treat analysis)
Notes Type 1 trial (no attempt to obtain IPD as not an intention-to-treat analysis).
Lost to follow-up: 32%.
Not an intention-to-treat analysis as 72 patients were excluded after randomisation
including any day patients transferred to a closed ward for more than 28 days
Risk of bias
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Schene-NL-1993 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomised”. No further details given
but 14 later withdrawn because of “incor-
rect randomisation procedure”
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
Incomplete outcome data (attrition bias)
All outcomes
High risk On admission: “21 (9%) of all randomized
patients had to be transferred to a closed
ward”; “10 (5%) patients did not accept
the result of the randomization” “28 (13%)
patients decided [...] against admission” “4
patients (2%) refused to participate in the
study” “9 (4%) were excluded for other rea-
sons”. 31 (21%) patients had dropped out
by discharge, 12 (8%) patients dropped out
at 6 month follow up (“admission less than
28days”; “transfer to a closedward formore
than 28 days”; “patients’ refusal to partici-
pate”)
Selective reporting (reporting bias) High risk Not all expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Supported by grants from the
Prevention Fund and National Fund for
Mental Health (Netherlands)
Sledge-US-1996
Methods Allocation: computer-generated randomisation by a researcher unaware of patient char-
acteristics - however, if no bed available candidate was allocated to the other condition.
Blindness: no (evaluation by rater independent of treating clinician, but not blind to
group allocation).
Follow up: discharge, 2, 5, 10 months.
Setting: day hospital of a community mental health centre day hospital.
Analysis: intention to treat.
Place: New Haven, Connecticut, USA.
Participants Diagnosis: schizophrenia 39%, mood disorder 52%, other 9%.
N = 197.
Age: mean ~ 33 years.
Sex: M 51%, F 49%.
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Sledge-US-1996 (Continued)
History: presenting for inpatient admission, living locally, not involuntary, not too ill
for day patient treatment, not intoxicated or medically unwell
Interventions 1. Acute day hospital: crisis respite programme + ’back up’ bed if necessary, day hospital
= 20 patient facility with doctors, nurses, social workers, therapists, weekdays 9-3pm,
group work, control of symptoms & improvement of daily skills (N = 93).
2. Inpatient care: 36-bed unit with doctors & nursing staff, psychologist, mental health
workers + very active programme (N = 104)
Outcomes Lost to follow-up.
Readmitted.
Hospital service outcomes: duration of index admission (IPD), inpatient & day patient
days/month (IPD).
Mental state: BPRS.
Social functioning: SAS.
Costs of care.
Unable to use -
Global functioning: GAS (not an outcome in this review).
Mental state: SCL-90 (redundant measurement - BPRS also used).*
Quality of life: Connecticut Department of Health Quality of Life Survey (unpublished
scale).
Satisfaction: Satisfaction with Services Scale (unpublished scale)
Notes Type 1 trial (IPD obtained).
Lost to follow up: 28.4%.
* Our IPD analysis required us to choose between the two measure of mental state
(BPRS or SCL 90) used in this study - BPRS was chosen because it was more similar
to the CPRS used in the two Creed studies - the two scales have similar effect sizes in
Sledge-US-1996.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “Random assignment”; “if a consenting pa-
tient was randomly assigned to a treatment
setting that was full [...] the patient was as-
signed (i.e. “rolled over” or switched) to the
other condition.”
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
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Sledge-US-1996 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “Attrition from the panel of 197 patients
who completed the initial interview was
7% (N = 14) at the discharge interview,
25% (N = 49) at the 2-month follow-up,
25% (N = 49) at the 5-month follow-up,
and 28% (N = 55) at the 10-month follow-
up”
Selective reporting (reporting bias) Low risk Expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Supported by grant SMH-47638
from the Substance Abuse and Mental
Health Source Administration (USA)
Wiersma-NL-1989
Methods Allocation: randomisation by block.
Blindness: no (evaluation by independent raters who were not blind to group allocation)
.
Follow-up: 1 and 2 years.
Setting: acute day hospital operated by the Regional Institute for Ambulatory Mental
Health Care.
Analysis: intention to treat.
Place: Groningen, Netherlands.
Participants Diagnosis: schizophrenia 33.1%, mood disorder 30.1%, other 36.8%.
N = 160.
Age: mean ~ 42 years.
Sex: M 50%, F 50%.
History: presenting for admission, forensic patients on court order and patients with
dementia
Interventions 1. Acute day hospital: admitted as soon as considered no risk to self or others, weekdays
8.30-16.30, could be inpatient for 1-2 nights on demand, 24 hr on call line to nurse (N
= 103).
2. Routine inpatient (N = 57).
Outcomes Lost to follow-up.
Deaths.
Readmitted.
Unemployed.
Hospital service outcomes: days in hospital care (IPD).
Mental state: PSE (IPD).
Social functioning: Groningen Social Disability Scale (IPD).
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Wiersma-NL-1989 (Continued)
Notes Type 2 trial (IPD obtained).
Lost to follow up: 41% at 2 years.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomised in blocks”. No further details
given.
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only 34 of the 54 schizophrenic patients
(68%) participated in the 2 year interviews,
24 (71%) of 34 experimental and 10 (63%)
of 16 controls. No further details given
Selective reporting (reporting bias) High risk Not all expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Source of support not reported
Zwerling-US-1964
Methods Allocation: randomisation via list held by phone answering service (fixed ratio).
Follow up: 2 years.
Evaluation: by rater independent of treating clinician, but not blind to group allocation.
Setting: acute day hospital.
Analysis: not an intention to treat analysis, patients with organic brain disease were
randomised but then excluded.
Coutry: New York, USA.
Participants Diagnosis: not reported.
N = 378.
Age: not reported.
Sex: not reported.
History: people about to be admittedwere allocated today hospital or inpatient treatment
Interventions 1. Acute day hospital: group oriented activities + family therapy, reviewed twice weekly,
weekdays (N = 189).
2. Routine inpatient care (N = 189).
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Zwerling-US-1964 (Continued)
Outcomes Unable to use -
Leaving the study early (8% lost, but proportion from each group not reported)
Deaths (not an intention-to-treat analysis, people with organic brain disease were ex-
cluded from the study after randomisation).
Readmitted (not an intention-to-treat analysis, people with organic brain disease were
excluded from the study after randomisation)
Notes Type 2 trial (unable to contact).
Lost to follow-up: 8%.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random list of “D” (day hospital) and
“I” (inpatient) prepared and numbered se-
quentially. Day hospital project book con-
tained the number sequence. Each patient
entered into the book in sequence
Allocation concealment (selection bias) Low risk Telephone answering service revealed name
and number of patient, and then the ran-
dom designation of “D” or “I”
Blinding (performance bias and detection
bias)
All outcomes
High risk Not blind.
Incomplete outcome data (attrition bias)
All outcomes
High risk Reasons for rejection of patients designated
to day hospitalisation: 22 (34%) had med-
ical or surgical problems, 2 patients did
not have family to provide medical care at
home, 9 (14%) had travel complications,
20 (31%) patients behaviour required 24-
hour hospitalisation. In 8 cases, patients re-
mained in inpatient care after being admit-
ted during the night or weekend
Selective reporting (reporting bias) High risk Not all expected outcomes reported.
Other bias Unclear risk No sample size calculation. Protocol not
available. Supported by a grant from the
National Institute of Mental Health (MH-
01132)
General abbreviations
~ - approximately
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CPN - Community Psychiatric Nurse
IPD - individual patient data
OT - Occupational therapist
Scales
BPRS - Brief Psychological Rating Scale
CIS - Clinical Interview Schedule
CPRS - Comprehensive Psychopathological Rating Scale
GAS - Global Assessment Scale
GHQ - General Health Questionnaire
PSE - Present State Examination
SCL 90 - Symptom Check List
SAS - Social Adjustment Scale
SBAS - Social Behaviour Assessment Schedule
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Austin-Los Angeles Allocation: not randomised, survey comparing randomly selected people from two different day hospitals
Azim-Alberta Allocation: not randomised, quasi-experimental design, comparing inpatients, day hospital patients and
non-patient controls
Barkley-Ontario Allocation: not randomised, retrospective study.
Basker-Jerusalem Allocation: not randomised, before and after design.
Bateman-London Allocation: randomised.
Participants: people with personality disorders.
Intervention: care in a psychotherapeutic day hospital versus outpatient care, not acute day hospital care
versus admission
Beigel-New York Allocation: not randomised, quasi-experimental design, comparing people who completed a partial hospi-
talisation program with those who dropped out
Bertrand-Belgium Allocation: not randomised.
Boath-Stoke Allocation: not randomised, quasi-experimental design comparing people in a day treatment program for
post-natal depression with controls in primary care
Bowman-Dublin Allocation: not randomised, survey examining differences between people admitted day hospital and in-
patient care
Bradshaw-Minnesota Allocation: randomised.
Participants: people with schizophrenia who were long term attenders at a day care centre.
Intervention: day care + cognitive behavioural therapy versus day care alone, not acute day hospital care
versus admission
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(Continued)
Brook-Denver Allocation: not randomised, survey comparing people treated in a crisis hostel with those treated in inpatient
care
Carey-US Allocation: randomised.
Participants: attenders at a day care centre who also abused substances.
Intervention: problem-solving training + day care versus day care alone, not acute day hospital care versus
admission
Case-New York Allocation: not randomised, retrospective study.
Comstock-Texas Allocation: not randomised, retrospective multivariate analysis
Creed-Blackburn Allocation: randomised by sealed envelope, however, the trialists judged that the randomisation procedure
had been compromised as people allocated to the day hospital condition were much less disabled that those
admitted to inpatient care (available data bear this out in terms of diagnosis and behaviour)
Creed-Manchester Allocation: not randomised, quasi-experimental study comparing consecutive admission to day hospital
and inpatient care
Dal Santo 2004 Allocation: not randomised.
Davidson 2006 Allocation: randomised.
Intervention: CBT versus TAU, not day hospital versus inpatient care
Dick-Dundee Allocation: randomised.
Participants: patients with chronic anxiety and depression.
Intervention: day hospital versus continuing outpatient care, not acute day hospital care versus admission
Drake-New Hampshire Allocation: not randomised, quasi-experimental design, comparing day treatment with supported employ-
ment program
Ettlinger-New York Allocation: not randomised, case-control study of day hospital versus inpatient care
Fink-Toronto Allocation: not randomised, quasi-experimental study of inpatient care versus day patient care
Glick-New York Allocation: randomised (method not clear).
Participants: people with severe mental illness recently discharged from hospital.
Interventions: transitional day hospital programme versus out patient follow-up, not acute day hospital
care versus admission
Glick-San Francisco Allocation: randomised.
Participants: people requiring hospital inpatient care.
Intervention: short versus long hospital admission, not acute day hospital care versus admission
Grad-Chichester Allocation: not randomised, quasi-experimental design comparing community care in two towns
Gudeman-Boston Allocation: not randomised, before and after design.
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(Continued)
Guidry-New Orleans Allocation: not randomised, before and after design.
Guillette-Maryland Allocation: not randomised, survey comparing costs of day patient care with theoretical costs of inpatient
care
Guy-Baltimore Allocation: randomised by sealed envelope.
Participants: people with a variety of psychiatric disorders referred for day care.
Intervention: day hospital treatment versus outpatient care, not acute day hospital care versus admission
Herz-New York2 Allocation: randomised (method not specified).
Participants: people with acute psychiatric disorders about to be admitted to inpatient care.
Interventions: routine inpatient care versus brief inpatient care versus brief inpatient plus day care, not
acute day hospital care versus admission
Hirsch-London Allocation: random allocation (method not specified).
Participants: people with acute psychiatric disorders about to be admitted to inpatient care.
Interventions: brief inpatient care with some use of day hospital (47% patients in the brief care group were
exposed to day hospital) versus routine inpatient care, not acute day hospital care versus admission
Hogg-Glasgow Allocation: not randomised, a survey comparing long term inpatients with long term day patients
Inch-Saskatchewan Allocation: not randomised, a prospective study comparing day hospital patients receiving ’therapeutic’
and ’non-therapeutic’ discharges
Jarema-Warsaw Allocation: not randomised, a survey comparing quality of life scores between day hospital patients, inpa-
tients and outpatients
Kandel-US Allocation: randomised.
Participants: adult general psychiatry patients attending a day treatment program.
Intervention: day treatment plus a small group intervention compared against day treatment, in order to
assess effect on “future time perception”, not acute day hospital care versus admission
Kecmanovic-Sarajevo Allocation: not randomised, case-control study comparing discharged inpatients with discharged day pa-
tients
Klyczek-US Allocation: not randomised, quasi-experimental design comparing outcome in two day hospitals, one of
which offered mainly psychotherapy, whilst the other offered mainly activity therapy
Konieczynska-Warsaw Allocation: not randomised, follow-up study comparing the outcome for patients treated in a day hospital,
inpatient ward and community mental health team
Kuldau-California Allocation: randomised.
Participants: inpatients about to be discharged.
Interventions: rapid discharge from inpatient care versus community transitional system (34%subjects of
intervention group were discharged via day hospital), not acute day hospital care versus admission
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(Continued)
Levenson-Houston Allocation: randomised by table of random numbers.
Participants: people with acute schizophrenia.
Intervention: treatment in an outpatient clinic versus hospital admission, excluded as outpatient clinic
does not meet criteria for day hospital
Liang-Taipei Allocation: not randomised, a survey comparing quality of life in patients in various care settings, including
day hospitals
Linn-USA Allocation: randomised by sealed envelope.
Participants: people with schizophrenia about to be discharged from hospital.
Interventions: day hospital treatment or outpatient care, not acute day hospital care versus admission
Lystad-Louisiana Allocation: not randomised, quasi-experimental design.
Mathai-Bangalore Allocation: not randomised, survey.
McDonnell-Ireland Allocation: not randomised, case report of a day hospital care in Dublin, Ireland
Meltzoff-New York Allocation: randomised by sealed envelope.
Participants: people with a variety of mental disorders referred for day care.
Interventions: day hospital treatment versus outpatient care, not acute day hospital care versus admission
Michaux 1969 Allocation: not randomised.
Michaux-Maryland Allocation: not randomised, quasi-experimental study of inpatient care versus day hospital care
Milne-Wakefield Allocation: not randomised, quasi-experimental study.
Newton-US Allocation: inadequate randomisation procedure, participants assigned alternatively to inpatient (even
numbered) or day hospital (odd numbered)
Niskanen-Helsinki Allocation: not randomised, compared patients before and after treatment in a day hospital
O’Shea-Ireland Allocation: not randomised, retrospective cost-effectiveness analysis comparing day patients and inpatients
Odenheimer-USA Allocation: not randomised, survey of the relatives of day hospital patients
Oka-Kurume-Japan Allocation: not randomised, quasi-experimental design comparing outcome in 31 patients with schizophre-
nia entering a day care centre with that of 30 outpatients with schizophrenia matched for age and sex
Pang-US Allocation: not randomised, narrative review.
Penk-Dallas Allocation: not randomised, case-control study of day hospital versus inpatient care
Piersma-Michigan Allocation: not randomised, quasi-experimental study compared improvement in a group of inpatients
with that in a group in day hospital
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(Continued)
Piper-Alberta Allocation: randomised.
Participants: outpatients with affective and personality disorders.
Intervention: outpatient treatment of day hospital care, not acute day hospital care versus admission
Platt-London Allocation: randomised.
Participants: people with acute psychiatric disorders
Intervention: admission to day hospital versus inpatient care, trial abandoned when insufficient people
(10) were randomised in first 10 weeks. No data available
Prior-Middlesex Allocation: not randomised.
Russell-Ottawa Allocation: not randomised, outcome for day patients compared with a retrospectively obtained sample of
inpatients
Sandell-Stockholm Allocation: not randomised, cohort study.
Shek 2009 Allocation: not randomised, systematic review.
Participants: acutely ill.
Skoda-Czech Republic Allocation: randomised.
Participants: people with neurosis, not schizophrenia.
Tam-Hong Kong Allocation: not randomised, survey comparing day patients with inpatients on demographic and psycho-
logical variables
Tantam-Manchester Allocation: not randomised, case-control study of a rehabilitation treatment for long-stay day patients
Tsukahara 1998 Allocation: not randomised.
Tyrer-Southampton Allocation: randomised by sealed envelope.
Participants: people with depression and anxiety.
Interventions: outpatient treatment versus two varieties of day care, not acute day hospital care versus
admission
Vaglum-Oslo Allocation: not randomised, follow-up study comparing outcome in day patients with different types of
personality disorder
Vaitl-Haar-Germany Allocation: not randomised, retrospective study comparing outcome in patients treated at day hospitals
with those treated at “night” hospitals
Van Den Hout-NL Allocation: randomised.
Participants: depressed patients on a day treatment program.
Intervention: self-control therapy plus day care versus day care, not acute day hospital care versus admission
Washburn-Boston Allocation: randomised, method not specified.
Participants: women receiving inpatient treatment.
Intervention: continuing inpatient admission versus discharge to day patient care, not acute day hospital
care versus admission
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Weissert 1980 Allocation: randomised.
Participants: chronically ill, no mention of acute psychiatric disorders
Welburn-Ottawa Allocation: not randomised, quasi-experimental design in which outcome for patients participating in a
psychotherapy-oriented day treatment program was compared against outcome for those awaiting admis-
sion to the program
Weldon-New York Allocation: randomised, method not specified.
Participants: people about to be discharged from inpatient care.
Intervention: day hospital treatment versus outpatient care, not acute day hospital care versus admission
Wilberg-Oslo Allocation: not randomised, quasi-experimental study of day treatment + psychotherapy versus day treat-
ment alone, for people with borderline personality disorder
Wu 1995 Allocation: randomised.
Intervention: sulpiride vs olanzapine vs sulpiride + olanzapine.
(translated with support from Cochrane Schizophrenia Group).
Characteristics of studies awaiting assessment [ordered by study ID]
Vietze-Germany
Methods
Participants
Interventions
Outcomes
Notes Reference in German, awaiting translation.
Characteristics of ongoing studies [ordered by study ID]
Donnison 2001
Trial name or title An evaluation of the clinical effectiveness of cognitive-behavioural rapid stabilisation group therapy in a day
hospital setting
Methods Allocation: randomised.
Participants History: people considered suitable for day hospital admission.
Exclusion criteria: active psychosis; in the manic phase of bipolar disorder; substance misuse which comprises
a person’s ability to participate
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Donnison 2001 (Continued)
Interventions 1. Cognitive behavioural group therapy: aimed at rapid stabilisation in combination with treatment as usual
(TAU)
2. TAU alone.
Outcomes Mental state: Brief Symptom Inventory (BSI), Beck Depression Inventory (BDI), Beck
Hopelessness Scale (BHS), Hospital Anxiety and Depression Scale.
General state: The General Health Questionnaire (GHQ).
Social functioning: Social Functioning Scale (SFS).
Cognition: Cognitive Skills Survey.
Satisfaction: a client satisfaction measure.
Starting date 1 April 2001
Contact information Ms Jenny Donnison
Community Health Sheffield NHS Trust
Eastglade Centre
1 EastGlade Crescent
Sheffield
S12 4QN
UK
Telephone: (0114) 271 6454
Fax: (0114) 271 6450
Notes
Gjonbalaj-Marovic 2005
Trial name or title Brief Community Linkage Intervention for Dually Diagnosed Individuals
Methods Allocation: randomised.
Participants History: inclusion criteria - patients over 18 years old; have a substance abuse disorder +diagnosis of schizophre-
nia, schizoaffective disorder, or bipolar I disorder; seeking outpatient treatment for the above disorders from
the VA; physically mobile, agree to take public transportation if they do not have other private sources.
Exclusion criteria - patients who only have either a mental health problem, or a substance abuse problem,
but not both; who do not have a residence where they can stay upon discharge from hospital; who are not
sufficiently medically or psychiatrically stable to participate in residential or outpatient treatment; could be re-
evaluated for study once stabilised; exclusively engaged in methadone maintenance programs; who represent
a serious suicide risk
Interventions 1. Time limited case management.
2. Health education.
Outcomes Service use: show rate at outpatient day treatment centre, day treatment attended, days re-hospitalised
Completion.
Global state: Global Level of Functioning, alcohol use, illicit drug use
Starting date June 2005
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Gjonbalaj-Marovic 2005 (Continued)
Contact information Selvija Gjonbalaj-Marovic
(973) 676-1000
selvija.gjonbalajmarovic@va.gov
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Day patient verus inpatient care for Type 1 studies
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Feasibility and engagement: lost
to follow-up (at end of study)
7 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 by 3 months 1 1117 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.80, 1.17]
1.2 by 6 months 2 312 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.58, 1.19]
1.3 by about 1 year 5 1694 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.82, 1.08]
2 Extent of hospital care: 1a.
duration of index admission
4 1582 Mean Difference (IV, Random, 95% CI) 27.47 [3.96, 50.98]
3 Extent of hospital care: 1b.
duration of index admission
(Type 1 additional data)
Other data No numeric data
4 Extent of hospital care: 2.
duration of all hospital care
(days/month)
3 465 Mean Difference (IV, Fixed, 95% CI) -0.38 [-1.32, 0.55]
5 Extent of hospital care: 3.
duration of day patient care
(adjusted days/month)
3 465 Mean Difference (IV, Fixed, 95% CI) 2.34 [1.97, 2.70]
6 Extent of hospital care: 4.
duration of stay in hospital
(days/month)
3 465 Mean Difference (IV, Fixed, 95% CI) -2.75 [-3.63, -1.87]
7 Extent of hospital care: 5.
readmitted to in/day patient
care after discharge
5 667 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.72, 1.15]
8 Mental state: average endpoint
score (BPRS, high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 at admission 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.08 [-0.13, -0.03]
8.2 at discharge 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.01 [-0.07, 0.05]
8.3 at 3 months 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.05 [-0.11, 0.01]
8.4 at 12 months 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.05 [-0.11, 0.01]
9 Social functioning: average
overall role score (GSDS-II,
high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 at admission 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.13 [-0.20, -0.06]
9.2 at discharge 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.34 [-0.48, -0.20]
9.3 at 3 months 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.10 [-0.19, -0.01]
9.4 at 12 months 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.11 [-0.19, -0.03]
10 Burden: average carers’ score
(SBAS, high = poor)
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
10.1 at 14 days 1 85 Mean Difference (IV, Fixed, 95% CI) 0.27 [-2.58, 3.12]
10.2 at 1 month 1 95 Mean Difference (IV, Fixed, 95% CI) -0.04 [-2.54, 2.46]
10.3 at 2 months 1 95 Mean Difference (IV, Fixed, 95% CI) 0.65 [-1.33, 2.63]
10.4 at 3 months 2 160 Mean Difference (IV, Fixed, 95% CI) -0.59 [-1.62, 0.44]
10.5 at 12 months 1 65 Mean Difference (IV, Fixed, 95% CI) -0.69 [-2.14, 0.76]
11 Death (all causes) 2 1207 Risk Ratio (M-H, Fixed, 95% CI) 0.18 [0.02, 1.54]
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11.1 all-cause death 1 90 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.97]
11.2 deaths (suicide and
untoward events)
1 1117 Risk Ratio (M-H, Fixed, 95% CI) 0.12 [0.01, 2.41]
12 Unemployed (at end of study) 2 320 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.67, 0.97]
13 Satisfaction with care: 1. not
satisfied with care received
1 91 Risk Ratio (M-H, Fixed, 95% CI) 0.46 [0.27, 0.79]
14 Satisfaction with care: 2.
average overall score (CAT, low
= poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
14.1 at admission 1 1117 Mean Difference (IV, Fixed, 95% CI) 0.22 [-0.04, 0.48]
14.2 at discharge 1 1117 Mean Difference (IV, Fixed, 95% CI) 0.06 [-0.18, 0.30]
15 Costs of care: 1. raw data Other data No numeric data
16 Costs of care: 2. percent
differences in costs
Other data No numeric data
17 Quality of life: average overall
role score (MANSA, low =
poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
17.1 at admission 1 1117 Mean Difference (IV, Fixed, 95% CI) -0.02 [-0.13, 0.09]
17.2 at discharge 1 1117 Mean Difference (IV, Fixed, 95% CI) 0.01 [-0.12, 0.14]
17.3 at 3 months 1 1117 Mean Difference (IV, Fixed, 95% CI) 0.11 [-0.02, 0.24]
17.4 at 12 months 1 1117 Mean Difference (IV, Fixed, 95% CI) 0.01 [-0.13, 0.15]
Comparison 2. Day patient versus inpatient care for Type 2 trials (all presenting for admission were randomised)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Feasibility and engagement: lost
to follow-up (at 2 years)
1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.48, 0.99]
2 Extent of hospital care: 1.
duration of all hospital care
(days/month, IPD - ”nights in”
& ”nights out”)
1 160 Mean Difference (IV, Fixed, 95% CI) 1.10 [-1.58, 3.78]
3 Extent of hospital care: 2.
readmitted to in/day patient
care after discharge
1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.64, 1.35]
4 Mental state: average endpoint
score (PSE 9, high = poor, IPD)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 at baseline 1 114 Mean Difference (IV, Fixed, 95% CI) 0.54 [-4.33, 5.41]
4.2 at 12 months 1 81 Mean Difference (IV, Fixed, 95% CI) 1.87 [-2.89, 6.63]
4.3 at 24 months 1 85 Mean Difference (IV, Fixed, 95% CI) 2.19 [-1.00, 7.38]
5 Social functioning: average
overall role score (Groningen
Scale, IPD)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 at baseline 1 106 Mean Difference (IV, Fixed, 95% CI) -0.11 [-0.45, 0.23]
5.2 at 12 months 1 95 Mean Difference (IV, Fixed, 95% CI) -0.25 [-0.62, 0.12]
5.3 at 24 months 1 95 Mean Difference (IV, Fixed, 95% CI) -0.19 [-0.58, 0.20]
6 Death (all causes) 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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6.1 deaths (suicide and
untoward events)
1 160 Risk Ratio (M-H, Fixed, 95% CI) 2.79 [0.14, 57.10]
6.2 deaths (other causes) 1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.37 [0.06, 2.14]
6.3 deaths all causes 1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.17, 3.18]
7 Unemployed (at end of study) 1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.87, 1.04]
8 Costs of care: 1. raw data Other data No numeric data
9 Costs of care: 2. percent
differences in costs
Other data No numeric data
Analysis 1.1. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 1 Feasibility and
engagement: lost to follow-up (at end of study).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 1 Feasibility and engagement: lost to follow-up (at end of study)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 by 3 months
Kallert-EU-2007 163/596 147/521 100.0 % 0.97 [ 0.80, 1.17 ]
Subtotal (95% CI) 596 521 100.0 % 0.97 [ 0.80, 1.17 ]
Total events: 163 (Day patients), 147 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.32 (P = 0.75)
2 by 6 months
Herz-US-1971 11/45 7/45 14.6 % 1.57 [ 0.67, 3.69 ]
Schene-NL-1993 26/99 46/123 85.4 % 0.70 [ 0.47, 1.05 ]
Subtotal (95% CI) 144 168 100.0 % 0.83 [ 0.58, 1.19 ]
Total events: 37 (Day patients), 53 (Hospital admission)
Heterogeneity: Chi2 = 2.82, df = 1 (P = 0.09); I2 =64%
Test for overall effect: Z = 1.02 (P = 0.31)
3 by about 1 year
Dick-UK-1985 5/43 3/48 1.0 % 1.86 [ 0.47, 7.33 ]
Creed-UK-1990 19/51 13/51 4.7 % 1.46 [ 0.81, 2.63 ]
Creed-UK-1996 23/94 23/93 8.3 % 0.99 [ 0.60, 1.63 ]
Sledge-US-1996 19/93 37/104 12.6 % 0.57 [ 0.36, 0.93 ]
Kallert-EU-2007 208/596 191/521 73.4 % 0.95 [ 0.81, 1.11 ]
Subtotal (95% CI) 877 817 100.0 % 0.94 [ 0.82, 1.08 ]
Total events: 274 (Day patients), 267 (Hospital admission)
Heterogeneity: Chi2 = 7.27, df = 4 (P = 0.12); I2 =45%
Test for overall effect: Z = 0.87 (P = 0.39)
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Analysis 1.2. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 2 Extent of
hospital care: 1a. duration of index admission.
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 2 Extent of hospital care: 1a. duration of index admission
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Creed-UK-1990 41 101.6 (82.8) 48 46.1 (62.9) 19.5 % 55.50 [ 24.53, 86.47 ]
Creed-UK-1996 90 91.6 (78.6) 89 55.8 (58.2) 24.2 % 35.80 [ 15.55, 56.05 ]
Kallert-EU-2007 596 78 (73) 521 46 (46) 28.8 % 32.00 [ 24.93, 39.07 ]
Sledge-US-1996 93 31.8 (44) 104 36.4 (41.8) 27.4 % -4.60 [ -16.62, 7.42 ]
Total (95% CI) 820 762 100.0 % 27.47 [ 3.96, 50.98 ]
Heterogeneity: Tau2 = 486.73; Chi2 = 31.87, df = 3 (P<0.00001); I2 =91%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 3 Extent of
hospital care: 1b. duration of index admission (Type 1 additional data).
Extent of hospital care: 1b. duration of index admission (Type 1 additional data)
Study Duration day patient Duration in patient Notes
Dick-UK-1985 median 34 days median 20 days after adjustment
Herz-US-1971 mean 48.5 days mean 138.8 days no statistical test reported
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Analysis 1.4. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 4 Extent of
hospital care: 2. duration of all hospital care (days/month).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 4 Extent of hospital care: 2. duration of all hospital care (days/month)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Creed-UK-1990 41 5.8 (4.65) 48 5.41 (5.96) 17.9 % 0.39 [ -1.82, 2.60 ]
Creed-UK-1996 90 4.31 (4.97) 89 5.42 (5.29) 38.5 % -1.11 [ -2.61, 0.39 ]
Sledge-US-1996 93 5.08 (4.97) 104 5.14 (5.13) 43.7 % -0.06 [ -1.47, 1.35 ]
Total (95% CI) 224 241 100.0 % -0.38 [ -1.32, 0.55 ]
Heterogeneity: Chi2 = 1.57, df = 2 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 5 Extent of
hospital care: 3. duration of day patient care (adjusted days/month).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 5 Extent of hospital care: 3. duration of day patient care (adjusted days/month)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Creed-UK-1990 41 4.35 (3.82) 48 0.75 (2.13) 7.7 % 3.60 [ 2.28, 4.92 ]
Creed-UK-1996 90 3.45 (3.1) 89 0.73 (1.84) 24.0 % 2.72 [ 1.97, 3.47 ]
Sledge-US-1996 93 2.85 (1.65) 104 0.79 (1.5) 68.3 % 2.06 [ 1.62, 2.50 ]
Total (95% CI) 224 241 100.0 % 2.34 [ 1.97, 2.70 ]
Heterogeneity: Chi2 = 6.06, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 12.54 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 6 Extent of
hospital care: 4. duration of stay in hospital (days/month).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 6 Extent of hospital care: 4. duration of stay in hospital (days/month)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Creed-UK-1990 41 1.44 (3.83) 48 4.67 (5.79) 19.0 % -3.23 [ -5.24, -1.22 ]
Creed-UK-1996 90 1.7 (4.43) 89 4.91 (5.19) 38.6 % -3.21 [ -4.62, -1.80 ]
Sledge-US-1996 93 2.24 (4.89) 104 4.35 (4.75) 42.4 % -2.11 [ -3.46, -0.76 ]
Total (95% CI) 224 241 100.0 % -2.75 [ -3.63, -1.87 ]
Heterogeneity: Chi2 = 1.49, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 6.13 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 7 Extent of
hospital care: 5. readmitted to in/day patient care after discharge.
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 7 Extent of hospital care: 5. readmitted to in/day patient care after discharge
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Creed-UK-1990 8/51 18/51 17.4 % 0.44 [ 0.21, 0.93 ]
Creed-UK-1996 25/94 20/93 19.4 % 1.24 [ 0.74, 2.07 ]
Dick-UK-1985 8/43 10/48 9.1 % 0.89 [ 0.39, 2.06 ]
Herz-US-1971 15/45 20/45 19.3 % 0.75 [ 0.44, 1.27 ]
Sledge-US-1996 36/93 38/104 34.7 % 1.06 [ 0.74, 1.52 ]
Total (95% CI) 326 341 100.0 % 0.91 [ 0.72, 1.15 ]
Total events: 92 (Day patients), 106 (Hospital admission)
Heterogeneity: Chi2 = 6.21, df = 4 (P = 0.18); I2 =36%
Test for overall effect: Z = 0.78 (P = 0.44)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 8 Mental state:
average endpoint score (BPRS, high = poor).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 8 Mental state: average endpoint score (BPRS, high = poor)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 at admission
Kallert-EU-2007 596 1.94 (0.415023) 521 2.02 (0.410858) 100.0 % -0.08 [ -0.13, -0.03 ]
Subtotal (95% CI) 596 521 100.0 % -0.08 [ -0.13, -0.03 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.23 (P = 0.0012)
2 at discharge
Kallert-EU-2007 596 1.51 (0.439436) 521 1.52 (0.524985) 100.0 % -0.01 [ -0.07, 0.05 ]
Subtotal (95% CI) 596 521 100.0 % -0.01 [ -0.07, 0.05 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.73)
3 at 3 months
Kallert-EU-2007 596 1.57 (0.439436) 521 1.62 (0.502159) 100.0 % -0.05 [ -0.11, 0.01 ]
Subtotal (95% CI) 596 521 100.0 % -0.05 [ -0.11, 0.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.76 (P = 0.079)
4 at 12 months
Kallert-EU-2007 596 1.52 (0.463849) 521 1.57 (0.524985) 100.0 % -0.05 [ -0.11, 0.01 ]
Subtotal (95% CI) 596 521 100.0 % -0.05 [ -0.11, 0.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.68 (P = 0.094)
Test for subgroup differences: Chi2 = 3.34, df = 3 (P = 0.34), I2 =10%
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Analysis 1.9. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 9 Social
functioning: average overall role score (GSDS-II, high = poor).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 9 Social functioning: average overall role score (GSDS-II, high = poor)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 at admission
Kallert-EU-2007 596 1.12 (0.610328) 521 1.25 (0.639112) 100.0 % -0.13 [ -0.20, -0.06 ]
Subtotal (95% CI) 596 521 100.0 % -0.13 [ -0.20, -0.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.46 (P = 0.00053)
2 at discharge
Kallert-EU-2007 596 0.9 (0.805633) 521 1.24 (1.392351) 100.0 % -0.34 [ -0.48, -0.20 ]
Subtotal (95% CI) 596 521 100.0 % -0.34 [ -0.48, -0.20 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.90 (P < 0.00001)
3 at 3 months
Kallert-EU-2007 596 0.82 (0.683567) 521 0.92 (0.776064) 100.0 % -0.10 [ -0.19, -0.01 ]
Subtotal (95% CI) 596 521 100.0 % -0.10 [ -0.19, -0.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.27 (P = 0.023)
4 at 12 months
Kallert-EU-2007 596 0.77 (0.683567) 521 0.88 (0.753239) 100.0 % -0.11 [ -0.19, -0.03 ]
Subtotal (95% CI) 596 521 100.0 % -0.11 [ -0.19, -0.03 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.54 (P = 0.011)
Test for subgroup differences: Chi2 = 9.69, df = 3 (P = 0.02), I2 =69%
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Analysis 1.10. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 10 Burden:
average carers’ score (SBAS, high = poor).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 10 Burden: average carers’ score (SBAS, high = poor)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 at 14 days
Creed-UK-1996 41 9.32 (7.19) 44 9.05 (6.11) 100.0 % 0.27 [ -2.58, 3.12 ]
Subtotal (95% CI) 41 44 100.0 % 0.27 [ -2.58, 3.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.19 (P = 0.85)
2 at 1 month
Creed-UK-1996 46 7.74 (7.03) 49 7.78 (5.22) 100.0 % -0.04 [ -2.54, 2.46 ]
Subtotal (95% CI) 46 49 100.0 % -0.04 [ -2.54, 2.46 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
3 at 2 months
Creed-UK-1996 50 6.18 (5.46) 45 5.53 (4.36) 100.0 % 0.65 [ -1.33, 2.63 ]
Subtotal (95% CI) 50 45 100.0 % 0.65 [ -1.33, 2.63 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
4 at 3 months
Creed-UK-1990 32 2.81 (2.32) 34 3.53 (2.72) 71.7 % -0.72 [ -1.94, 0.50 ]
Creed-UK-1996 48 5.06 (4.77) 46 5.33 (4.81) 28.3 % -0.27 [ -2.21, 1.67 ]
Subtotal (95% CI) 80 80 100.0 % -0.59 [ -1.62, 0.44 ]
Heterogeneity: Chi2 = 0.15, df = 1 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.13 (P = 0.26)
5 at 12 months
Creed-UK-1990 32 2.22 (2.37) 33 2.91 (3.49) 100.0 % -0.69 [ -2.14, 0.76 ]
Subtotal (95% CI) 32 33 100.0 % -0.69 [ -2.14, 0.76 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Chi2 = 1.65, df = 4 (P = 0.80), I2 =0.0%
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Analysis 1.11. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 11 Death (all
causes).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 11 Death (all causes)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 all-cause death
Herz-US-1971 0/45 1/45 28.7 % 0.33 [ 0.01, 7.97 ]
Subtotal (95% CI) 45 45 28.7 % 0.33 [ 0.01, 7.97 ]
Total events: 0 (Day patients), 1 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
2 deaths (suicide and untoward events)
Kallert-EU-2007 0/596 3/521 71.3 % 0.12 [ 0.01, 2.41 ]
Subtotal (95% CI) 596 521 71.3 % 0.12 [ 0.01, 2.41 ]
Total events: 0 (Day patients), 3 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 1.38 (P = 0.17)
Total (95% CI) 641 566 100.0 % 0.18 [ 0.02, 1.54 ]
Total events: 0 (Day patients), 4 (Hospital admission)
Heterogeneity: Chi2 = 0.20, df = 1 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 1.56 (P = 0.12)
Test for subgroup differences: Chi2 = 0.20, df = 1 (P = 0.66), I2 =0.0%
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Analysis 1.12. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 12 Unemployed
(at end of study).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 12 Unemployed (at end of study)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Creed-UK-1996 42/90 47/89 45.2 % 0.88 [ 0.66, 1.19 ]
Kris-US-1965 43/71 57/70 54.8 % 0.74 [ 0.60, 0.93 ]
Total (95% CI) 161 159 100.0 % 0.81 [ 0.67, 0.97 ]
Total events: 85 (Day patients), 104 (Hospital admission)
Heterogeneity: Chi2 = 0.90, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.020)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 13 Satisfaction
with care: 1. not satisfied with care received.
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 13 Satisfaction with care: 1. not satisfied with care received
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Dick-UK-1985 12/43 29/48 100.0 % 0.46 [ 0.27, 0.79 ]
Total (95% CI) 43 48 100.0 % 0.46 [ 0.27, 0.79 ]
Total events: 12 (Day patients), 29 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 2.84 (P = 0.0044)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 14 Satisfaction
with care: 2. average overall score (CAT, low = poor).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 14 Satisfaction with care: 2. average overall score (CAT, low = poor)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 at admission
Kallert-EU-2007 596 7.55 (2.075114) 521 7.33 (2.282542) 100.0 % 0.22 [ -0.04, 0.48 ]
Subtotal (95% CI) 596 521 100.0 % 0.22 [ -0.04, 0.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.68 (P = 0.094)
2 at discharge
Kallert-EU-2007 596 8.12 (1.928636) 521 8.06 (2.077114) 100.0 % 0.06 [ -0.18, 0.30 ]
Subtotal (95% CI) 596 521 100.0 % 0.06 [ -0.18, 0.30 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
Test for subgroup differences: Chi2 = 0.81, df = 1 (P = 0.37), I2 =0.0%
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Analysis 1.15. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 15 Costs of care:
1. raw data.
Costs of care: 1. raw data
Study Index Ad.
(DP)
Index Ad.
(IP)
Hosp. Care
(DP)
Hosp. Care
(IP)
All Psy Care
(DP)
All Psy Care
(IP)
Total cost
(DP)
Total cost
(IP)
Creed-UK-
1990
Not known Not known £4847
(3310-
6384)
£6396
(4277-
8515)
Not known Not known Not known Not known
Creed-UK-
1996
Not known Not known £4101
(2852-
5351)
£6809
(5388-
8231)
£4653
(3339-
5966)
£7379
(5886-
8872)
£5695
(2483-
8907)
£7487
(5339-
9636)
Dick-UK-
1985
£307.3 £610.0 Not known Not known Not known Not known Not known Not known
Sledge-US-
1996
$13239
(9189-
17288)
$19903
(15906-
23899)
$24376
(18567-
30186)
$30747
(24904-
36590)
$26819
(20933-
32705)
$33916
(27940-
39893)
Not known Not known
69Day hospital versus admission for acute psychiatric disorders (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.16. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 16 Costs of care:
2. percent differences in costs.
Costs of care: 2. percent differences in costs
Study Index Admission Hospital care All psychiatric care All costs care Notes
Creed-UK-1990 -49.6% (no test) Not known Not known Not known
Creed-UK-1996 Not known -24.2% (p=0.675) Not known Not known
Dick-UK-1985 Not known -39.8% (p<0.001) -36.9% (p<0.001) -23.9% (p=0.014)
Sledge-US-1996 -33.5% (p<0.001) -20.7% (p=0.012) -20.9% (p=0.009) Not known - indicates DH is cheaper
Mann Whitney Tests
Analysis 1.17. Comparison 1 Day patient verus inpatient care for Type 1 studies, Outcome 17 Quality of life:
average overall role score (MANSA, low = poor).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 1 Day patient verus inpatient care for Type 1 studies
Outcome: 17 Quality of life: average overall role score (MANSA, low = poor)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 at admission
Kallert-EU-2007 596 3.95 (0.976524) 521 3.97 (0.958668) 100.0 % -0.02 [ -0.13, 0.09 ]
Subtotal (95% CI) 596 521 100.0 % -0.02 [ -0.13, 0.09 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.73)
2 at discharge
Kallert-EU-2007 596 4.37 (1.09859) 521 4.36 (1.186922) 100.0 % 0.01 [ -0.12, 0.14 ]
Subtotal (95% CI) 596 521 100.0 % 0.01 [ -0.12, 0.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
3 at 3 months
Kallert-EU-2007 596 4.44 (1.09859) 521 4.33 (1.141271) 100.0 % 0.11 [ -0.02, 0.24 ]
Subtotal (95% CI) 596 521 100.0 % 0.11 [ -0.02, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.64 (P = 0.10)
-1 -0.5 0 0.5 1
Favours day patients Favours inpatients
(Continued . . . )
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(. . . Continued)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
4 at 12 months
Kallert-EU-2007 596 4.51 (1.147416) 521 4.5 (1.209747) 100.0 % 0.01 [ -0.13, 0.15 ]
Subtotal (95% CI) 596 521 100.0 % 0.01 [ -0.13, 0.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Chi2 = 2.29, df = 3 (P = 0.51), I2 =0.0%
-1 -0.5 0 0.5 1
Favours day patients Favours inpatients
Analysis 2.1. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 1 Feasibility and engagement: lost to follow-up (at 2 years).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission were randomised)
Outcome: 1 Feasibility and engagement: lost to follow-up (at 2 years)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wiersma-NL-1989 36/103 29/57 100.0 % 0.69 [ 0.48, 0.99 ]
Total (95% CI) 103 57 100.0 % 0.69 [ 0.48, 0.99 ]
Total events: 36 (Day patients), 29 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 2.01 (P = 0.045)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours day patients Favours inpatients
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Analysis 2.2. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 2 Extent of hospital care: 1. duration of all hospital care (days/month, IPD -
“nights in” & “nights out”).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission were randomised)
Outcome: 2 Extent of hospital care: 1. duration of all hospital care (days/month, IPD - ”nights in” % ”nights out”)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Wiersma-NL-1989 103 7.48 (8.39) 57 6.38 (8.22) 100.0 % 1.10 [ -1.58, 3.78 ]
Total (95% CI) 103 57 100.0 % 1.10 [ -1.58, 3.78 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours day patients Favours inpatients
Analysis 2.3. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 3 Extent of hospital care: 2. readmitted to in/day patient care after discharge.
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission were randomised)
Outcome: 3 Extent of hospital care: 2. readmitted to in/day patient care after discharge
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wiersma-NL-1989 42/103 25/57 100.0 % 0.93 [ 0.64, 1.35 ]
Total (95% CI) 103 57 100.0 % 0.93 [ 0.64, 1.35 ]
Total events: 42 (Day patients), 25 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.38 (P = 0.70)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours day patients Favours inpatients
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Analysis 2.4. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 4 Mental state: average endpoint score (PSE 9, high = poor, IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission were randomised)
Outcome: 4 Mental state: average endpoint score (PSE 9, high = poor, IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 at baseline
Wiersma-NL-1989 77 21.3 (12.48) 37 20.76 (12.38) 100.0 % 0.54 [ -4.33, 5.41 ]
Subtotal (95% CI) 77 37 100.0 % 0.54 [ -4.33, 5.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.83)
2 at 12 months
Wiersma-NL-1989 55 12.49 (12.93) 26 10.62 (8.62) 100.0 % 1.87 [ -2.89, 6.63 ]
Subtotal (95% CI) 55 26 100.0 % 1.87 [ -2.89, 6.63 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
3 at 24 months
Wiersma-NL-1989 60 10.55 (11.45) 25 8.36 (10.98) 100.0 % 2.19 [ -3.00, 7.38 ]
Subtotal (95% CI) 60 25 100.0 % 2.19 [ -3.00, 7.38 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Chi2 = 0.24, df = 2 (P = 0.89), I2 =0.0%
-10 -5 0 5 10
Favours day patients Favours inpatients
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Analysis 2.5. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 5 Social functioning: average overall role score (Groningen Scale, IPD).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission were randomised)
Outcome: 5 Social functioning: average overall role score (Groningen Scale, IPD)
Study or subgroup Day patients Hospital admission
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 at baseline
Wiersma-NL-1989 74 2.42 (0.81) 32 2.53 (0.84) 100.0 % -0.11 [ -0.45, 0.23 ]
Subtotal (95% CI) 74 32 100.0 % -0.11 [ -0.45, 0.23 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
2 at 12 months
Wiersma-NL-1989 67 2.21 (0.86) 28 2.46 (0.84) 100.0 % -0.25 [ -0.62, 0.12 ]
Subtotal (95% CI) 67 28 100.0 % -0.25 [ -0.62, 0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
3 at 24 months
Wiersma-NL-1989 67 2.06 (0.87) 28 2.25 (0.89) 100.0 % -0.19 [ -0.58, 0.20 ]
Subtotal (95% CI) 67 28 100.0 % -0.19 [ -0.58, 0.20 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Chi2 = 0.30, df = 2 (P = 0.86), I2 =0.0%
-1 -0.5 0 0.5 1
Favours day patients Favours inpatients
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Analysis 2.6. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 6 Death (all causes).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission were randomised)
Outcome: 6 Death (all causes)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 deaths (suicide and untoward events)
Wiersma-NL-1989 2/103 0/57 100.0 % 2.79 [ 0.14, 57.10 ]
Subtotal (95% CI) 103 57 100.0 % 2.79 [ 0.14, 57.10 ]
Total events: 2 (Day patients), 0 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.51)
2 deaths (other causes)
Wiersma-NL-1989 2/103 3/57 100.0 % 0.37 [ 0.06, 2.14 ]
Subtotal (95% CI) 103 57 100.0 % 0.37 [ 0.06, 2.14 ]
Total events: 2 (Day patients), 3 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 1.11 (P = 0.27)
3 deaths all causes
Wiersma-NL-1989 4/103 3/57 100.0 % 0.74 [ 0.17, 3.18 ]
Subtotal (95% CI) 103 57 100.0 % 0.74 [ 0.17, 3.18 ]
Total events: 4 (Day patients), 3 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 0.41 (P = 0.68)
0.01 0.1 1 10 100
Favours day patients Favours inpatients
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Analysis 2.7. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 7 Unemployed (at end of study).
Review: Day hospital versus admission for acute psychiatric disorders
Comparison: 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission were randomised)
Outcome: 7 Unemployed (at end of study)
Study or subgroup Day patients Hospital admission Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wiersma-NL-1989 93/103 54/57 100.0 % 0.95 [ 0.87, 1.04 ]
Total (95% CI) 103 57 100.0 % 0.95 [ 0.87, 1.04 ]
Total events: 93 (Day patients), 54 (Hospital admission)
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.28)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours day patients Favours inpatients
Analysis 2.8. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 8 Costs of care: 1. raw data.
Costs of care: 1. raw data
Study Hosp. care (DP) Hosp. care (IP) All Psy Care (DP) All Psy Care (IP)
Wiersma-NL-1989 Dfl 43928 (33535-
54319)
Dfl 35990 (23375-
48604)
Dfl 48377 (38005-
58748)
Dfl 38252 (25684-
50821)
Analysis 2.9. Comparison 2 Day patient versus inpatient care for Type 2 trials (all presenting for admission
were randomised), Outcome 9 Costs of care: 2. percent differences in costs.
Costs of care: 2. percent differences in costs
Study Hospital care All psychiatric care Notes
Wiersma-NL-1989 +22.0% (p=0.175) +26.4% (p=0.057) + indicates DH is more expensive
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A D D I T I O N A L T A B L E S
Table 1. Feasibility and engagement: 1. proportion suitable for day hospital (Type 1)
Study Eligible
(pess)
Eligible
(opt)
Ran-
domised
Rand day
hosp
Rand & en-
gaged
% feasible
(opt)
% feasible
(pess)
Kris-US-65 ? ? not applica-
ble
not applica-
ble
? ? ? (see text)
Herz-US-71 424 310 90 45 35 29.0 16.5
Dick-UK-
85
334 203 75 43 37 36.9 19.3
Creed-UK-
90
185 175 102 51 35 58.3 37.8
Schene-NL-
93
534 534 199 ? ? 37.3 ? (see text)
Creed-UK-
96
? ? not applica-
ble
not applica-
ble
? ? ? (see text)
Sledge-US-
96
791 546 197 93 93 36.1 24.9
Overall type
1
2268 1768 663 232 200 37.5 (95%
CI 35.2-39.
8)
23.2 (95%
CI 21.2-25.
2)
Table 2. Type 1 trials: data schedule for individual patient data
Trial Mental State Social Functioning
Creed-UK-1990 0, 3 & 12 months 0, 3 & 12 months
Creed-UK-1996 0, 6 & 12 months 0, 0.5, 1, 2, 3, 6 & 12 months
Sledge-US-1996 2, 5 & 10 months 0, 2, 5 & 10 months
Table 3. Type 1 trials: summary of covariates used in the individual patient analysis
Co-variate Creed 1990 (IP) Creed 1990
(DP)
Creed 1996 (IP) Creed 1996
(DP)
Sledge 1996
(IP)
Sledge 1996
(DP)
N randomised 51 51 93 94 104 93
N included in
analysis
47 40 84 84 98 91
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Table 3. Type 1 trials: summary of covariates used in the individual patient analysis (Continued)
Males (%) 26 (55) 23 (58) 45 (54) 46 (55) 56 (57) 42 (46)
Females (%) 21 (45) 17 (42) 39 (46) 38 (45) 42 (43) 49 (54)
< 24 yrs 2 (4) 4 (10) 14 (17) 14 (17) 15 (15) 15 (16)
25-34 20 (42) 10 (25) 23 (27) 24 (28) 43 (44) 42 (46)
35-44 7 (15) 6 (15) 25 (30) 17 (20) 23 (23) 20 (22)
45-54 8 (17) 7 (18) 13 (15) 9 (11) 10 (10) 11 (12)
> 55 10 (21) 13 (32) 9 (11) 20 (24) 7 (7) 3 (3)
Bipolar or scz 18 (38) 14 (35) 40 (48) 31 (40) 56 (57) 46 (50)
Other diagnosis 29 (62) 26 (65) 44 (52) 53 (60) 42 (43) 45 (49)
Table 4. Mental state: model coefficients for standardised mental state scores
Parameters Model Coeff. (SE) 95% CI P value
FIXED EFFECTS
Time intervention interaction
(months)
-0.007 (0.0022) -0.011 to -0.002 0.002
Time (months) -0.073 (0.0067) -0.086 to -0.059
Gender (0 = female, 1 = male) 0.018 (0.0642) -0.110 to 0.147 0.777
Diagnosis (0 = other, 1 = scz or
bpd)
0.054 (0.0648) -0.076 to 0.184 0.406
Age 0.019 (0.1124) -0.206 to 0.244 0.862
Study 2 (Creed-UK-1996) -0.046 (0.0899) -0.225 to 0.134
Study 3 (Sledge-US-1996) 0.084 (0.0948) -0.106 to 0.273 0.189
Intervention group 0.144 (0.0671) 0.009 to 0.278 0.032
Constant 0.229 (0.1303) -0.026 to 0.485
RANDOMEFFECTS (patient
level)
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Table 4. Mental state: model coefficients for standardised mental state scores (Continued)
Constant (intercept) 0.211 (0.0324) n/a
Constant*time (weeks) 0.001 (0.0007) n/a
Time gradient (weeks) 0.00008 (0.00003) n/a
RANDOM EFFECTS (time
level)
Constant (error) 0.508 (0.0225) n/a
Table 5. Social functioning: model coefficients for standardised social functioning score
Parameters Model Coeff (SE) 95% CI P value
FIXED EFFECTS
Time-intervention interaction
(months)
-0.001 (0.0121) -0.025 to 0.023 0.941
Time (months) -0.052 (0.0087) -0.069 to -0.034
Gender 0.404 (0.0862) 0.231 to 0.576 0.001
Diagnosis 0.087 (0.0854) -0.084 to 0.257 0.310
Age -0.100 (0.0356) -0.171 to -0.028 0.005
Study 2 (Creed-UK-1996) -0.010 (0.1158) -0.241 to 0.222
Study 3 (Sledge-US-1996) -0.010 (0.1094) -0.229 to 0.209 0.995
Intervention group -0.041 (0.1098) -0.261 to 0.179 0.708
Constant 0.344 (0.1698) 0.011 to 0.677
RANDOM EFFECTS
Patient level (constant - inter-
cept)
0.313 (0.0440) n/a
Time level (constant - error) 0.565 (0.0343) n/a
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Table 6. Feasibility and engagement: 2. proportion suitable for day hospital (Type 2)
Study Eligible Randomised Rand day hosp Mainly in DH % feasible
Wiersma-NL-89 160 160 103 19 18.4
Zwerling-US-64 278 189 189 74 39.1
A P P E N D I C E S
Appendix 1. Search methods for identification of studies on the previous version of the review
a. Electronic searches
The search began by deriving a list of search terms from reading overviews of the field and consulting experts in day hospital care. The
reference databases listed below were searched using Ovid Biomed.
1. CINAHL (January 1982 - December 2000) was searched using the Cochrane Schizophrenia Group’s search strategy for randomised
controlled trials combined with the phrase: [((DAY adj2 HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*) or (DAY adj2
CENT*) or (DAY adj2 UNIT*) or (PARTIAL adj2 HOSP*) or (DISPENSARY)) ANDMENTAL DISORDERS].
2. The Cochrane Library (Issue 4, 2000) was searched using the phrases: [((DAY near HOSP*) or (DAY near CARE) or (DAY near
TREATMENT*) or (DAY near CENT*) or (DAY near UNIT*) or (PARTIAL near HOSP*) or (DISPENSARY)) AND MENTAL
DISORDERS exploded].
3. EMBASE (January 1980 - December 2000) was searched using the Cochrane Schizophrenia Group’s search strategy for randomised
controlled trials combined with the phrase: [((DAY adj2 HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*) or (DAY adj2
CENT*) or (DAY adj2 UNIT*) or (PARTIAL adj2 HOSP*) or (DISPENSARY)) ANDMENTAL DISORDERS].
4. MEDLINE (January 1966 -December 2000) was searched using the Cochrane Schizophrenia Group’s search strategy for randomised
controlled trials combined with the phrase: [((DAY adj2 HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*) or (DAY adj2
CENT*) or (DAY adj2 UNIT*) or (PARTIAL adj2 HOSP*) or (DISPENSARY)) AND MENTAL DISORDERS/All subheadings
exploded].
5. PsycLIT (January 1967 - December 2000) was searched using the Cochrane Schizophrenia Group’s search strategy for randomised
controlled trials combined with the phrase: [((DAY adj2 HOSP*) or (DAY adj2 CARE) or (DAY adj2 TREATMENT*) or (DAY adj2
CENT*) or (DAY adj2 UNIT*) or (PARTIAL adj2 HOSP*) or (DISPENSARY)) ANDMENTAL DISORDERS].
b. Searching other resources
1. Reference searching
The sensitivity of the search strategy was examined by comparing the results of the search with the reference lists of the identified
reviews and trials, but no new trials were identified.
2. Personal contact
Researchers in the field were approached to identify unpublished studies.
80Day hospital versus admission for acute psychiatric disorders (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 2. Modifications to original protocol
1. After writing the initial protocol it became obvious that it would be difficult to synthesis summary data from the included trials
because of the range and complexity of the outcome variables that had been used. For example, one key outcome, use of hospital care,
had been reported in terms of days in inpatient care, duration of day patient care, adjusted duration of day care (discounting weekends
and days off ), duration of index admission, nights out of hospital, actual attendances at day care, readmission to day care, readmission
to inpatient care and so on. The result was that whilst most acute day hospital trials reported similar outcomes, these outcomes were
rarely in the same format and hence could not be combined across trials. The picture was further complicated because many of the
outcome variables were skewed, and tended to be presented in forms (such as medians) which cannot be readily synthesised in a meta
analysis. It was therefore considered essential to obtain individual patient data from included trials so that the relevant outcomes could
be presented in a common format.
2. The original protocol proposed to look at a number of different ways of using day hospitals, in addition to using them as an alternative
to admission. This was too large a project to be contained in a single review, so alternative uses of day hospitals are covered in a separate
review (Marshall 2001).
3. The original protocol did not propose to look at feasibility of day hospital treatment. On reading the original papers and reviews it
became clear that this was an important question that should be addressed by the review. Feasibility was therefore added to the list of
outcomes.
WH A T ’ S N E W
Last assessed as up-to-date: 17 February 2011.
Date Event Description
17 February 2011 New search has been performed New search carried out June 2010, results incorporated
into review.
Protocol: methods section updated.
17 February 2011 New citation required but conclusions have not
changed
One new study added to included studies, three studies
added to excluded studies, no substantive change to
results
H I S T O R Y
Protocol first published: Issue 1, 1999
Review first published: Issue 1, 2003
Date Event Description
22 October 2008 Amended Converted to new review format.
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C O N T R I B U T I O N S O F A U T H O R S
Max Marshall - conceived the review and obtained funding, designed the review, co-ordinated the review and collected the data,
developed and screened the results of the search strategy, appraised papers and extracted data, compiled the individual patient data
and cross-checked it against the trial reports, carried out the analyses of individual patient data other than mental state and social
functioning, interpreted the data and wrote the final report.
Ruth Crowther - co-ordinated the review and collected the data, updated the searches, cross-checked the data extraction, managed the
data for the review and entered data on RevMan, compiled the individual patient data and cross-checked it against the trial reports,
and advised on the final report.
William Sledge - prepared and provided individual patient data, provided additional information about their trials as requested, advised
on interpretation of data, and the final report.
John Rathbone - extracted data for 2011 update.
Karla Soares-Weiser - extracted data and rewrite of text 2011 update.
D E C L A R A T I O N S O F I N T E R E S T
Francis Creed, William Sledge, Herman Kluiter and Durk Wiersma have carried out trials of acute day hospital treatment.
S O U R C E S O F S U P P O R T
Internal sources
• Guild Community Healthcare Trust, UK.
External sources
• NHS Health Technology Assessment - grant no. 96/41/3, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The protocol has been updated to reflect new methodology used in Cochrane reviews, for example inclusion of Summary of findings
for the main comparison.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Day Care, Medical; ∗Hospitalization; Acute Disease; Length of Stay; Mental Disorders [∗therapy]; Psychotic Disorders [therapy];
Randomized Controlled Trials as Topic
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MeSH check words
Humans
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